日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  24(2)

日本癌治療学会 [編]

[目次]

• Presidential Lecture An Approach for Development of Immunotherapy Using Cancer-specific Effector Lymphocytes From the Patients with Gynecologic Malignancy--Based on the Characteristics Shared by Malignant and Embryonic Cells Including Tropho-blantic Cells. / S.Takeuchi / p149～149
• Special Lecture 1. Not Received / /
• Special Lecture 2. Oncogene Studies and Their Implications on Cancer Treatment / T.Kawakami
• T.Honjo / p150～150
• Invitational Lecture 1. Current Management of Ovarian Carcinoma:A Time for Reassessment? / W.T.Creasman / p151～151
• Invitational Lecture 2. Angiogenesis in Tumor Growth and Metastasis:The Potential Role of Angiogenesis Inhibitors / J.Folkman / p152～153
• Invitational Lecture 3. Present Status of Adjuvant Therapy in Breast Cancer (Chemotherapy and/or Endocrine Therapy) / R.E.Wilson / p154～154
• Educational Lecture 1. Not Received / /
• Educational Lecture 2. Information System to Support Cancer Treatments / S.Kaihara et al. / p155～155
• Educational Lecture 3. Adult T-cell Leukemia/Lymphoma(ATL) / K.Takatsuki / p156～156
• Educational Lecture 4. Establishment of Tumor-specific Immunotherapy through the T Cell-T Cell Interaction between Haptenic Determinants and Tumor-resistance Antigens on Tumor Cells / T.Hamaoka / p157～157
• Educational Lecture 5. Clinical Application of Cytokines to Cancer Treatment / I.Urushizaki / p158～158
• Educational Lecture 6. Nutritional Management in Cancer Therapy / T.Muto / p159～159
• Symposium 1 Recent Progress in Cancer Therapy in a Specialized Organ Giving Useful Informations to the Other Specialized Fields -Part 1- / / p160～164
• 1. Not Received / /
• 2. On Behalf of Japanese Society of Biological Response Modifiers / K.Ishihara / p160～160
• 3. On the Activity of the Japanese Research Society for Surgical Cancer Immunology / K.Orita / p161～161
• 4. Activities of the Japanese Society for Arterial Infusion Chemotherapy Research / T.Taguchi / p162～162
• 5. Assays for Evaluating the Chemosensitivity of Human Tumors / H.Ichihashi / p163～163
• 6. Present Situation of Hyperthermia in Cancer Therapy / M.Abe / p164～164
• Symposium 2 Recent Progress in Cancer Therapy in a Specialized Organ Giving Useful Informations to the Other Specialized Fields -Part 2- / / p165～170
• 1. Hyperthermia Combined with Chemotherapy and Irradiation for the Treatment of Patients with Esophageal Carcinoma / K.Sugimachi / p165～165
• 2. The Recent Trend in the Treatment of Stomach Carcinoma and Its Link with the Treatment of Carcinomas in Other Organs / Y.Omori / p166～166
• 3. Multimodality Treatment for Carcinoma of the Pancreas / R.Tsuchiya et al. / p167～167
• 4. Prevention and Treatment of the Liver Metastasis from Cancer of the Large Intestine / M.Yasutomi et al. / p168～168
• 5. Malignant Lymphoma / S.Shirakawa et al. / p169～169
• 6. Childhood Solid Tumor / T.Fuiimoto / p170～170
• Symposium 3 Recent Progress in Cancer Therapy in a Specialized Organ Giving useful Informations to the Other Specialized Fields -Part 3- / / p171～175
• 1. Multidisciplinary Treatment for Malignant Brain Tumors / K.Takakura et al. / p171～171
• 2. Present Status of Breast Cancer Treatments and Future Prospects / Y.Nomura / p172～172
• 3. Lung Cancer / K.Suemasu et al. / p173～173
• 4. Not Received / /
• 5. Recent Progress in the Treatment of Urogenital Cancer / K.Koiso / p174～174
• 6. A Recent Trend in the Therapies for Skin Cancers / S.Ikeda / p175～175
• Symposium 4 Multi-disciplinary Treatment of Cancer--Has It Improved the Results of Treatment? / / p176～180
• 1. Multidisciplinary Treatment of Leukemia / T.Masaoka / p176～176
• 2. Multidisciplinary Treatment of Head and Neck Cancer / Y.Inuyama / p177～177
• 3. Recent Progress in Multidisciplinary Treatment of Hepatic Malignancy / M.Fujita et al. / p178～178
• 4. An Analysis of Factors Influential to the Improvement of the Survival Rate of Patients with Ovarian Cancer / M.Ohta et al. / p179～179
• 5. Multidisciplinary Treatment for Advanced Testicular Tumors / T.Kotake et al. / p180～180
• Symposium 5 Quality of Life in Cancer Therapy / / p181～184
• 1. Quality of Life in Cancer Treatment:Introduciton / F.Takaku / p181～181
• 2. Telling the Diagnosis of Cancer / T.Doi / p182～182
• 3. Cancer Pain Management / F.Takeda / p183～183
• 4. Quality of Life of the Terminally Ill Cancer Patient--From Experience in Hospice / T.Kashiwagi / p184～184
• 5. Not Received / /
• Symposium 6 Significance and Limitations of Extension of Surgery for Cancer / / p185～190
• 1. Extensive Lymphadenectomy for thoracic Esophageal Carcinoma / S.Mori et al. / p185～185
• 2. Extended Operations of Cancer--Gastric Cancer / K.Takagi / p186～186
• 3. The Value and Limit of Extended Operation for Colorectal Cancer / K.Hojo et al. / p187～187
• 4. Significance of Extended Operation for Pancreas Cancer / I.Miyazaki / p188～188
• 5. Primary Cytoreductive Surgery for Advanced Ovarian Cancer with Special Reference to the Significance of Bowel Resection / K.Sato et al. / p189～189
• 6. Extended Surgery for Renal Cell Carcinoma / Y.Aso et al. / p190～190
• Symposium 7 Adverse Effects and Their Measures in Cancer Therapy / / p191～195
• 1. Autologous Bone Marrow Transplantation as a Measures against Myelosuppression in Cancer Chemotherapy / T.Tajima et al. / p191～191
• 2. Not Received / /
• 3. Not Received / /
• Additional Utterance Clinical Studies and Pharmacokinetics of Cisplatin With High Dose of Bismuth Subnitrate / T.Morikawa et al. / p192～192
• 4. Adverse Reactions to Carcinostatics and the Counterplans / I.Nakao / p193～193
• 5. Infection and Immunosupression in Cancer Patients / T.Kitahara et al. / p194～194
• 6. The Surgical Stress and Immunosuppression in Cancer Therapy / T.Toge et al. / p195～195
• 7. Not Received / /
• Panel Discussion 1 New Developments of Tumor Markers / / p196～197
• 1. Serum Pepsinogen I Level in Stomach Cancer Patients--Its Values and Limitations in Clinical Use / K.Miki et al. / p196～196
• 2. Clinical Usefulness of Plasma PIVKA-II Assay and Its Limitations in Patients with Hepatocel-lular Carcinoma / S.Fujiyama et al. / p196～196
• 3. Diagnostic Usefulness and Limitation of Measurement of Pancreatic Cancer Associate Antigen,Span-1 in Patients with Pancreatic Cancer / K.Satake et al. / p196～196
• 4. The Usefulness and Limitation of Sugar Antigens in Ovarian Cancers--With Special Reference to a New Tumor Marker CA54/61 / S.Nozawa / p197～197
• 5. Clinical Application of Immunotoxin for Cancer Therapy
• Its Possibility and Problem / T.Yamaguchi et al. / p197～197
• Designated Discussion / N.Sawabu et al. /
• Panel Discussion 2 New Developments in Imaging Diagnosis for Cancer / / p198～200
• 1. NMR Spectroscopy of Tumors / M.Itoh et al. / p198～198
• 2. Computed Tomography(CT)and Magnetic Resonance Imaging(MRI)in the Diagnosis of Gynecologic Cancer / K.Takahashi / p198～198
• 3. DSA(Digital Subtraction Angiography)--Application of Intraarterial DSA of Bronchial Artery for Lung Cancer / Y.Kuroda / p198～198
• 4. New Diagnostic Tools Using Proton Beams Obtained from Accelerators in KEK Tsukuba / M.Suzuki et al. / p199～199
• 5. CCD Endoscope(Stomach) / Y.Okazaki / p199～199
• 6. Efficacy of Endoscopic Ultrasonography for Malignant Tumor of the Digestive Tract / S.Nakazawa et al. / p199～199
• 7. Radioimmunoscintigraphy in Malignant Melanoma with In-111 Labeled Monoclonal Anti-body 96.5 and ZME-018 / K.Ishii et al. / p200～200
• 8. Medical Physics and Cancer Diagnosis by Medical Images / A.Takeshi et al. / p200～200
• Panel Discussion 3 Mechanisms of Cancer Metastasis--Feedback for Clinical Application / / p201～202
• 1. Conversion of Tumor Cells from Regressor to Progressor Cells / H.Kobayashi et al. / p201～201
• 2. Not Received / /
• 3. Blood Coagulation and Metastasis / Y.Niitsu et al. / p201～201
• 4. Natural Killer Cells and Metastases / T.Kobayashi / p201～201
• 5. Metastatic Tumor and Fibrinolytic System / M.Yamamura et al. / p202～202
• 6. Chemotherapeutic Effect on Metastatic Tumors (`) / H.Takahashi et al. / p202～202
• 7. Metastatic Tumor and Immunotherapy / S.Fuchimoto et al. / p202～202
• Panel Discussion 4 Mechanisms of Drug Resistance of Cancer--Feedback for Clinical Application / / p203～204
• 1. Not Received / /
• 2. A Molecular Basis for Multidrug Resistance and Reversal of the Resistance / S.Akiyama et al. / p203～203
• 3. Drug Resistance in Lung Cancer Cells / K.Nakagawa et al. / p203～203
• 4. Detection of Drug Resistance in Human Hematologic Malignancy by Monoclonal Antibodies / M.Shimoyama et al. / p203～203
• 5. Effects of Cis-platinum and Adriamycin on Cell Kinetics of Human Ovarian Cancer cells in vitro and Its Characterization of Cisplatinum-resistance / I.Nishiya et al. / p204～204
• 6. Not Received / /
• Panel Discussion 5 Clinical Assessment of Second-look Operation in Cancer Therapy / / p205～207
• 1. Clinical Evaluation of Second Look Operation for Colorectal Cancer / K.Shindo et al. / p205～205
• 2. Clinical Evaluation of Second Look Operation in Colorectal Cancer / N.Saitoh et al. / p205～205
• 3. Second Look Operation of Recurrent Gastric Cancer / M.Niimoto et al. / p205～205
• 4. Gastric Remunant Cancer / K.Ishibiki et al. / p206～206
• 5. Reevaluation of Second Look Operation(SLO)in the Treatment of Ovarian Cancer Patients / K.Ochiai et al. / p206～206
• 6. Studies on Second Look Operation(SLO)for Ovarian Cancer / H.Yuzawa / p206～206
• 7. The Roles of Second Look Surgery in Neuroblastoma / S.Sawaguchi et al. / p207～207
• 8. Clinical Evaluation of Al Protocol for Advanced Neuroblastoma / M.Iwafuchi et al. / p207～207
• Panel Discussion 6 Cancer which is Curable by Chemotherapy Alone / / p208～209
• 1. Curable Cancer by Chemotherapy 1. Acute Myelogenous Leukemia(AML) / R.Ohno / p208～208
• 2. Malignant Lymphoma / N.Horikoshi / p208～208
• 3. Combination Chemotherapy with/without Radiation Therapy for Small Cell Lung Cancer:An Experience of Single Institution / T.Ohnoshi / p208～208
• 4. Gynecologic Malignancies Curable by Anticancer Chemotherapy--Choriocarcinoma and Ovarian Cancer / K.Kanazawa / p209～209
• 5. Clinical Evaluation of Chemotherapy for urologic Cancer / T.Miki et al. / p209～209
• Panel Discussion 7 Present Status of Cisplatin Analogue / / p210～211
• 1. A Prospect for Cisplatin Analogs from the Experimental Standpoint / T.Tashiro / p210～210
• 2. Pharmacokinetics of New Cisplatin Analogues in Experimental Animals / H.Fujita et al. / p210～210
• 3. Present Status of Cisplatin(CDDP)Analogues in Japan / H.Majima / p210～210
• 4. Preclinical and Clinical Evaluation of Toxicities and Antitumor Activities of Cisplatin Analogues / Y.Ariyoshi et al. / p211～211
• 5. Clinical Evaluation of Cisplatin Analogies in Urogenital Cancer / T.Machida / p211～211
• 6. Current Status of Cisplatin Analogs in Gynecologic Malignancies / M.Yakushiji et al. / p211～211
• Panel Discussion 8 Physical and Chemical Therapy Useful in Combined with Irradiation / / p212～214
• 1. Hypoxic Cell Radiosensitizer / T.Mori / p212～212
• 2. Experimental Study of Anti-tumor Activity of Direct Current / H.Ito et al. / p212～212
• 3. The Use of Direct Current for the Local Destruction of Cancer Tissues / M.Yokoyama / p212～212
• 4. A Study on Application of a Combined Treatment of Endoscopic Laser Irradiation and Radiotherapy on Advanced Lung Cancer / R.One et al. / p213～213
• 5. The Possibilities of Hyperthermia from Engineering Standpoint / Y.Saitoh et al. / p213～213
• 6. Biological Basis of Radiotherapy Combined with Physical-chemical treatments / S.Okada / p213～213
• 7. Clinical Aspects of Adjuvant Physico-chemical Therapy to Radiotherapy / S.Egawa / p214～214
• Panel Discussion 9 Developments in Adoptive Immunotherapy for Cancer / / p215～216
• 1. Adoptive Immunotherapy by Intra-arterial Infusion of ATLAK or Allo-TLAK Cells in Patients with Head and Neck Cancer / T.Ikawa et al. / p215～215
• 2. The Basic and Clinical Studies on Cytotoxic T Lymphocytes(CTl)Therapy against Cancer / K.Kitsukawa et al. / p215～215
• 3. Clinical and Experimental Studies on OK432-combined Adoptive Immunotherapy Using IL2-cultured Lymphocytes:A New Method to Augment the Therapeutic Effect / N.Kan et al. / p215～215
• 4. Not Received / /
• 5. Cultivation of Human Tumor Infiltrating Lymphocytes for Use in Adoptive Immunotherapy / P.Sekine et al. / p216～216
• 6. Not Received / /
• Panel Discussion 10 Roles of Therapy by Traditional Chinese Medicine in Cancer Therapy / / p217～220
• 1. Induction of Phenotypic Reverse Transformation by Plant Glycosides in Cultured Cancer Cells / S.Odashima et al. / p217～217
• 2. The Production of Antitumor or Immunostimulatory Cytokines by Some Traditional Chinese Medicines / S.Morisawa et al. / p217～217
• 3. Effects of Hochu-ekkito on Macrophage Activation / T.Tokunaga et al. / p217～217
• 4. Preventative Effect of TJ-48 on Recovery from Radiation Injury / S.Ikehara / p218～218
• 5. Not Received / /
• 6. Immunological Examination of JUZENTAIHO-TO(TJ-48) for Postoperative Gastric Cancer / T.Kurokawa et al. / p218～218
• 7. Preventing Effect of "Liuwei Dihuang Decoction"on Esophageal Carcinoma / J.Tingliang et al. / p218～218
• 8. Controlled Prospective Trial to Evaluate Syo-saiko-to for the Prevention of Hepatocellular Carcinoma in Patients with Cirrhosis of the Liver / S.Yamamoto et al. / p219～219
• 9. Protective Effects of Juzen-taiho-to on the Adverse Effects of Some Anti-tumour Agents / M.Yamashita / p219～219
• 10. Clinical Effects of Juzen-daiho-to on the Immunological and Fatty Metabolic States in the Postoperatic Patients with Gastro-intestinal Cancer / T.Okamoto et al. / p219～219
• 11. Role of Supporting Therapy of Juzentaiho-to(JTT)in Advanced Breast Cancer Patient / I.Adachi et al. / p220～220
• Panel Discussion 11 Present Status in Treatment of Trophoblastic Disease and Its Measures to be Taken in Future in Asia / / p221～221
• 1. Not Received / /
• 2. Not Received / /
• 3. Not Received / /
• 4. Not Received / /
• 5. Clinical Experience of Trophoblastic Disease in Nepal / H.Soma et al. / p221～221
• 6. Trophoblastic Disease in Japan / N.Obata / p221～221
• Workshop 1 Diagnosis and Treatment of Precancerous Lesions in Various Organs / / p222～226
• 1. Glandular Dysplasia of the Uterine Cervix--Cytological Diagnosis and a Follow-up Study / H.Higashiiwai et al. / p222～222
• 2. Diagnosis and Treatement of the Dysplasia of the Uterine Gervix / T.Kaku et al. / p222～222
• 3. Diagnosis and Treatment of Dysplais of the Uterine Cervix / T.Jobo et al. / p222～222
• 4. Laser Excisional Conization in the Treatment of Cervical Intraepithelial Neoplasia on an Outpatient Basis / T.Iwasaka et al. / p223～223
• 5. Diagnosis and Treatment of Endometrial Hyperplasia / K.Tanaka et al. / p223～223
• 6. Diagnosis of Precancerous Lesions of the Endometrium / H.Iwasaki et al. / p223～223
• 7. The Effect of Danazol and Tamoxifen on Endometrial Hyperplasia / E.Soh et al. / p224～224
• 8. Diagnosis and Treatment of Precancerous Lesions of the Bladder by Contact-micro-cystoscopy / M.Nakao et al. / p224～224
• 9. Follow-up Study of Precancerous Lesion in Breast / K.Enomoto et al. / p224～224
• 10. Photodynamic Diagnosis and Therapy of Precancerous Lesions of The Bronchus / H.Kato et al. / p225～225
• 11. Selective Brushings for all Branches of Bronchi:Diagnostic Values Thereof on Patients with Roentogenographically Occult Lung Cancer / M.Sato et al. / p225～225
• 12. Studies on the Pre-cancerous Lesion of the Colon / T.Igarashi et al. / p225～225
• 13. The Relationships between Dysplasia and Squamous Cell Carcinoma of the Esophagus / W.Takiyama et al. / p226～226
• 14. Malignant Progression on Oral Leukoplakia / A.Inoue et al. / p226～226
• 15. Not Received / /
• 16. Relation of Karyotypic Findings to Chemotherapy Response in Myelodysplastic Syndrome / S.Horiike et al. / p226～226
• Workshop 2 Clinical Pathology of Vulvar Tumor / / p227～231
• 1. A Clinico-pathological Study of Precancerous Lesions of the Vulva / M.Honma / p227～227
• 2. Clinical Study of 84 Primary Vulvar Carcinomas / T.Yamashiro et al. / p227～227
• 3. Clinicopathological Study of Early Vulval Cancer / H.Nakajima et al. / p227～227
• 4. Treatment for the Malignant Vulvar Diseases / T.Saito et al. / p228～228
• 5. The Comparative Study of Treatments for Vulvar Carcinomas / M.Yamasaki et al. / p228～228
• 6. Clinical Treatment Study of the Vulvar Cancer / S.Ikeda et al. / p228～228
• 7. Not Received / /
• 8. Study of Clinical Background and Therapeutic Method of Vulvar Cancer Patient / N.Umesaki et al. / p229～229
• 9. Human Papillomavirus DNA in Vulvar Lesions / S.Sato et al. / p229～229
• 10. Bowenid Papulosis and Bowen's Disease of Genital Region / M.Niimura / p229～229
• 11. A Case of Verrucous Anogenital Tumor Associated with Human Papillomavirus Infection / T.Nakajima et al. / p230～230
• 12. A Study on Human Papilloma Virus(HPV)in Penile Tumor / A.Iwasawa et al. / p230～230
• 13. Genital Paget's Disease / Y.Hayashibara et al. / p230～230
• 14. Clinical Symptom and Prognosis of Malignant Melanoma in Pubic Region / H.Sasaki et al. / p231～231
• 15. Surgical Treatment of Malignant Tumors of the External Genital Area / T.Sugihara et al. / p231～231
• Workshop 3 Improvements in Therapy for Primary Malignant Tumors in Bone and Soft Tissue of Extremities / / p232～236
• 1. Consideration of Preoperative Systemic Chemotheraphy for Osteosarcoma / H.Chuman et al. / p232～232
• 2. Limb-salvage Procedures for Malignant Bone Tumors--A Study of 54 Cases / H.Yoshikawa et al. / p232～232
• 3. Application of Preoperative Chemotherapy to Postoperative Chemotherapy for Malignant Bone and Soft Tissue Tumors / K.Furuse et al. / p232～232
• 4. Significance of Intra-arterial CDDP as Preoperative Treatment for Osteosarcoma / S.Masuda et al. / p233～233
• 5. Isolation Perfusion Chemotherapy Using Cisplatin for Malignant Tumor of the Extremity / S.Takeyama et al. / p233～233
• 6. Historical Improvement in Treatment for Osteosarcoma / H.Kawano et al. / p233～233
• 7. Angiotensin-induced Hypertension Chemotherapy for Bone and Soft-tissue Sarcomas / H.Tsuchiya et al. / p234～234
• 8. Preoperative Radiotherapy for Bone and Soft Tissue Sarcomas / S.Matsumoto et al. / p234～234
• 9. Hyperthermia for Malignant Tumors of the Extremities (3rd report) -Experimental Heating by Radio Waves and Its Clinical Significance- / N.Matsui et al. / p234～234
• 10. Limb Salvage Procedures for Malignant Bone Tumors of the Extremities / T.Morita et al. / p235～235
• 11. The Evaluation Method of Surgical Margin for Musculoskeletal Sarcoma / N.Kawaguchi et al. / p235～235
• 12. Limb-saving Surgery for Malignant Bone Tumor Using Massive Bone Grafts / S.Takeuchi et al. / p235～235
• 13. Massive Bone Allograft in Bone Tumor Surgery / N.Shinohara et al. / p236～236
• 14. Clinical Experience of 37 Cases of Soft Tissue Sarcomas in Recent 6 Years / H.Kakizaki et al. / p236～236
• Workshop 4 Application of the Newly Advanced Culture System to Cancer therapy / / p237～240
• 1. Not Received / /
• 2. Changes of DNA Synthetic Cells of Cervical Cancer Cases by Administration of CDDP at the Point of View in Cultured System / T.Izutsu et al. / p237～237
• 3. The Role of Flow Cytometrical Evaluation of De-differentiation in Human Neuro-blastoma NB6 Cell Line in vitro / H.Yamamoto et al. / p237～237
• 4. Mechanism of Action of Endocrine Therapy for Endometrial Carcinoma / H.Kuramoto et al. / p237～237
• 5. Monoclonal Antibodies Raised against Cultured Cells and Their Application to Cancer Diagnosis / S.Nozawa et al. / p238～238
• 6. Alteration of Phenotype or Drug Sensitivity in Cancer Cell Lines in Different Culture Conditions / J.Sakamoto et al. / p238～238
• 7. Development of a New Therapeutic Method of Hepatocelluler Carcinoma Using the Culture System--The Intensifying Effect on the Antitumor Action of Antitumor Agents / Y.Hata et al. / p238～238
• 8. In vitro Chemosensitivity Assay,the Scintillation Assay,and Its Clinical Application / N.Tanigawa et al. / p239～239
• 9. Culture of LAK Cells by the Use of Hollow-fiber Bioreactor System / U.Tanji et al. / p239～239
• 10. A New High Yield Continuous Cell Culture System and its Clinical Application for Adoptive Immunotherapy with LAK Cells / T.Noto et al. / p239～239
• 11. Effects of Thermotherapy on Human Esophageal Carcinoma in Culture and Its Clinical Study / T.Shinbo et al. / p240～240
• 12. Combination Therapy of Hyperthermia and other Methods for Liver and Bile Tract Cancers--Evaluation of These Methods with Cancer Cell Lines in vitro / S.Hasumura et al. / p240～240
• 13. The Therapeutic Effects of OK-432 Combined Adoptive Immunotherapy(AIT)against Liver Metastases of Breast Cancer / T.Okino et al. / p240～240
• Workshop 5 Role of Autopsy for Improvement of Cancer Therapy / / p241～243
• 1. Significance of Autopsy in the Cases of Gastric Carcinoma / T.Ishiko / p241～241
• 2. On the Role of Autopsy from The Viewpoint of Pathologists in the School of Medicine / Y.Ohnishi / p241～241
• 3. An Analysis of Autopsy Cases with Malignant Soft Tissue and Bone Tumors / M.Enjoji et al. / p241～241
• 4. Evaluation of Cancer Treatment by Autopsy / T.Sugiyama et al. / p242～242
• 5. The Clinicopathologic Analysis of 46 Autopsied Breast Cancer / S.Takashima et al / p242～242
• 6. Review of 43 Autopsy Cases with Urogenital Malignant Tumors / M.Yuasa et al. / p242～242
• 7. Autopsy Findings in 255 Cases of Head and Neck Cancer / S.Matsuura et al. / p243～243
• 8. Therapentic Analysis with Autopsy Findings Oral Cancer / H.Fukazawa et al. / p243～243
• General Lecture 1. Augmentation of General Immune Response of Mice with Transplanted Tumor by Oral Administration of OK-432 / Y.Akamatsu et al. / p244～244
• General Lecture 2. Not Received / /
• General Lecture 3. Augmentation of Natural Killer Activity of Hepatic Lymphocytes by Portal Administration of BRM / H.Murakami et al. / p244～244
• General Lecture 4. Chromomycin A₃as an Immunomodulator / M.Kambe et al. / p244～244
• General Lecture 5. Effects of Recombinant Murine Granulocyte-macrophage Colony-stimulating Factor(rmGM-CSF)on Survial Rate of Mice Infected with Pseudomonas Aeruginosa / T.Tanaka et al. / p245～245
• General Lecture 6. Anti-tumor Effect of Low Dose X-ray Irradiation in the Tumor-bearing Mice and Spleen Cell Movement / A.Sasaki et al / p245～245
• General Lecture 7. Effect of BRM on Kupffer Cells-with Special Reference to Superoxide Production and Tumoricidal Activity / T.Sasaoki et al. / p245～245
• General Lecture 8. Immunotherapy of Murine Renal Cancer(Renca)by OK-432 / S.Tanji et al. / p246～246
• General Lecture 9. The Effectiveness on Intratumoral Injection of Biological Response Modifiers as Adoptive Immunotherapy / M.Takahashi et al. / p246～246
• General Lecture 10. Experimental Study of Oral Administration of SSM (an Extract from Human Tubercle Bacilli) / K.Iida et al. / p246～246
• General Lecture 11. Prophylactic Effects of OK-432 and Anticancer Drugs on Hepatic Metastases of Mouse Colorectal Tumors / Y.Nishiyama et al. / p247～247
• General Lecture 12. Establishment of Anti-tumor Immunotherapy Utilizing Lactobacillus Casei(LC 9018) / Y.Shimizu et al. / p247～247
• General Lecture 13. The Suppression Effect of Repetitive Intraportal Administration of Recombinant Interleukin 2(rIL2)and Anticancer Drug for Liver Metastasis in Rabbit VX2 Model / M.Iwasaki et al. / p247～247
• General Lecture 14. Effect of Crude IL-2 on Cytotoxic Activity on Cultured Metastatic Lymphonode Lymphocyte in Murine Model / M.Nakanishi et al. / p248～248
• General Lecture 15. Anti-tumor Effect of Liposome-entrapped Tumor Necrosis Factor against Brain Tumor / J.Ishiyama et al. / p248～248
• General Lecture 16. Antitumor Effect of Recombinant Human Interleukin-1β in Combination with Natural Human Tumor Necrosis Factor-α and-β on BDF-1 Mice Bearing Lewis Lung Carcinoma / M.Ohkura et al. / p248～248
• General Lecture 17. Antiproliferative Effect of TNFs and IFNs on Experimental Hepatic Metastasis / E.Sanada et al. / p249～249
• General Lecture 18. Not Received / /
• General Lecture 19. Immunochemotherapy for Murine Bladder Tumor(MBT-2)with a New Recombinant Tumor Necrosis Factor(rTNF-S AM2) / T.Iizumi et al. / p249～249
• General Lecture 20. Enhancement of Walker-256 Antitumor Effect by Intraarterial Administration of TNF before Using Mitomycin C / T.Sato et al. / p249～249
• General Lecture 21. The Role of Intracellular Ca²⁺in the Mechanism of TNF-cytotoxicity / M.Maeda et al. / p250～250
• General Lecture 22. Enhanced Antitumor Effect against a Nonimmunogenic Tumor by Highly Immunogenic Variant Obtained by Mutagen Treatment / R.Sainouchi et al. / p250～250
• General Lecture 23. Augmentation of LAK Cell-Accumulation in the Region of Tumors by Cancer Chemotherapy / M.Hosokawa et al. / p250～250
• General Lecture 24. Life-prolonging Effect of Low-dose IL2 / N.Kan et al. / p251～251
• General Lecture 25. Studies on Administration and Efficacy of Autologous Lymphocytes Sensi-tized with Solid Tumor in Animal Model / M.Hirokawa et al. / p251～251
• General Lecture 26. Adoptive Immunotherapy of Advanced Visceral Metastases with in vitro Sensitized(IVS)Tlymphocytes from Tumor-bearing(TB)Mice / T.Chou et al. / p251～251
• General Lecture 27. The Antitumor Effective Research of Combinant Therapy of Mouse IFN-γ and Antitumor Medicine(CDDP) / M.Sugiyama et al. / p252～252
• General Lecture 28. Therapeutic Effect of Xenogenized Tumor Cell Vaccine Combined with Bleomycin(BLM)or Cyclophosphamide(CY)against Rat Fibrosarcoma / M.Komatsumoto et al. / p252～252
• General Lecture 29. Clinical Examination of Renal Pelvic and Ureteral Tumors / S.Uejima et al. / p252～252
• General Lecture 30. Statistical Analyses on Tumors of Renal Pelvis and Ureter / T.Nagai et al. / p253～253
• General Lecture 31. Statistical Studies of Superficial Bladder Tumor / K.Toyoda et al. / p253～253
• General Lecture 32. Statistical Study on Bladder Tumor / Y.Thachibana et al. / p253～253
• General Lecture 33. G3Tl Tumors in the Development of Transitional Cell Carcinoma of the Urinary Bladder / Y.Tanaka et al. / p254～254
• General Lecture 34. Uroepithelial Tumors of Upper Urinary Tract following the Therapy of Bladder Cancers / H.Ohashi et al. / p254～254
• General Lecture 35. Significance of Diagnosis and Treatment on Prostate Cancer Stage A / T.Hachiya et al. / p254～254
• General Lecture 36. Clinical Evaluation of Patients with Relapsed Prostatic Carcinoma / Y.Uekado et al. / p255～255
• General Lecture 37. Clinical Observations on Squamous Cell Carcinoma of the Penis / K.Fukuda et al. / p255～255
• General Lecture 38. Treatment for Penile Carcinoma-analysis on 14 Cases / T.Tsukamoto et al. / p255～255
• General Lecture 39. Clinical Studies on 29 Cases of Testicular Tumors / S.Kawamura et al. / p256～256
• General Lecture 40. A Clinicostatistical Analysis of Testicular Tumor / M.Saegusa et al. / p256～256
• General Lecture 41. Pathohistologicai and Immunological Resarch of Spontaneous Regression or Long Survival Cancer Cases (XIV) -The Analytical Study of the Gastric Cancer Patients- / S.Nakagawa et al / p256～256
• General Lecture 42. Autopsy Findings in 49 Cases of Esophageal Cancer / K.Sakaino et al. / p257～257
• General Lecture 43. Not Received / /
• General Lecture 44. A Study of the Recurrence in the Remnant Liver of Hepatocellular Carcinoma in Relation to the Mode of It's Growth / M.Yamamoto et al. / p257～257
• General Lecture 45. Clinico-pathological Investigation of 25 Leiomyosarcomas of Alimentary Tract / N.Kadoya et al. / p257～257
• General Lecture 46. Head and Neck Cancer in Aged Popuration / K.Hayasaki et al. / p258～258
• General Lecture 47. Neck Dissection Combined with Radiotherapy for the Metastatic Node,6cm in Diameter / H.Matsuura et al. / p258～258
• General Lecture 48. An Evaluation of the Treatment of Nonsquamous Cell Malignancies of the Nose and Paranasal Sinuses / M.Igarashi et al. / p258～258
• General Lecture 49. Clinical Study for the Promoting Factor of the Tongue Cancer in Younger Adults / Y.Kimura et al. / p259～259
• General Lecture 50. The Clinical and Pathological Study of Recurrent Thyroid Cancer / M.Sasaki et al. / p259～259
• General Lecture 51. Long Term Survivors in Small Cell Lung Cancer Patients / M.Yamamoto et al. / p259～259
• General Lecture 52. Clinical Study of the Treatment and Prognosis of Small Cell Lung Cancer(SCLC) / T.Tsuburaya et al. / p260～260
• General Lecture 53. Prognostic Factor in Patients with Primary Ovarian Cancer / T.Nakano et al / p260～260
• General Lecture 54. An Analysis of Prognostic Factors in Ovarian Cancer Patients with Poor Prognosis / T.Kita et al. / p260～260
• General Lecture 55. Clincal Evaluation of Chemotherapy for Ovarian Embfyonal Carcinoma / T.Chiba et al / p261～261
• General Lecture 56. Mass Screening for Uterine Cancer in Oita Prefecture after Enforcement of Rhozin Hokenlow / I.Taniguchi et al. / p261～261
• General Lecture 57. Not Received / /
• General Lecture 58. Occurrence of Choriocarcinoma after Chemotherapy for Invasive Mole / S.Hirose et al. / p261～261
• General Lecture 59. Choriocarcinoma Following Normal Labor-the Result of Registry in Shizuoka Prefecture and Three Cases Recently Seen in Our Hospital / M.Maeda et al. / p262～262
• General Lecture 60. Tumor Volume and Histologic Type in the Evaluation of Cervical Cancer Prognosis / Y.Nakai et al. / p262～262
• General Lecture 61. Adenocarcinomas and Mixed Carcinomas of the Uterine Cervix: Clinicopathological Study for the Prognostic Factors / I.Konishi et al. / p262～262
• General Lecture 62. Prognostic Significance of Langerhans Cell Infiltration in Adenocarcinoma of the Uterine Cervix / T.Nakano et al. / p263～263
• General Lecture 63. Study on Squamous Cell Carcinoma of the Uterine Cervix According to New FIGO Staging / Y.Gyotoku et al. / p263～263
• General Lecture 64. Study of Risk Factors in Postoperative Cases of the Endometrial Cancer / Y.Hashimoto et al. / p263～263
• General Lecture 65. Analysis of Prognostic Factors in Endometrial Carcinoma / S.Ohkawara et al. / p264～264
• General Lecture 66. Investigation on the Cases with Recurred Uterine Endometrial Cancer in Our Clinic / Y.Kondo et al. / p264～264
• General Lecture 67. Multivariate Analysis of Prognostic Factors for Renal Cell Carcinoma / K.Ohmura e tal. / p264～264
• General Lecture 68. Computerized Follow-up System of the Cancer Patients / K.Kaliwara et al. / p265～265
• General Lecture 69. Hazard Ratio Estimated from a Proportional Hazard Model Including Two Strongly Correlated Prognostic Factors / N.Hamajima et al. / p265～265
• General Lecture 70. Hypothesis of Combined Immune and Respiratory Disorders in Relation to the Nature of Cancer, and a Flow Chart of the Therapy / M.Mori / p265～265
• General Lecture 71. From Six Cases of Multiple Primary Malignant Neoplasm / K.Tsuchikawa et al. / p266～266
• General Lecture 72. Second Primary Malignancies in 373 Patients with Laryngeal Cancer / T.Fujii et al. / p266～266
• General Lecture 73. Early Gastric Carcinoma--With Special Reference to Postoperative Recurrence and Primary Carcinoma of Other Organs Following Gastrectomy / H.Maekawa et al. / p266～266
• General Lecture 74. A Cohort Study of Multiple Primary Cancer on 870 Gastrectomy Cases / M.Kamakura et al. / p267～267
• General Lecture 75. A Case Study of Double Malignancies, Chorangiocarcinoma and Adrenal Neuroblastoma Treated with Combined Chemotherapy Regimen of Cyclo-phosphamide,Vincristine,Adriamycin,and Dimethyl Triazeno Imidazole Cafrboxamide(CYVADIC) / T.Watanabe et al. / p267～267
• General Lecture 76. Multiple Primary Cancers Associated with Gynecologic Malignancies / M.Shinohara et al. / p267～267
• General Lecture 77. Phase II Clinical Study of 254-S[(Glycolato-O,O')Diammine Pt(II)],a New Platinum Complex,for Primary Lung Cancer (Prelimiary Report) / K.Kubota et al. / p268～268
• General Lecture 78. Phase II Study of 254-S for Non-small Cell Lung Cancer / M.Fukuda et al. / p268～268
• General Lecture 79. Phase II Study of 254-S for Gynecologic Malignancy / H.Nishimura et al. / p268～268
• General Lecture 80. Studies on Absorbing Pathways and Effect of KM2210(Bursamustin)on Recurrent and Advanced Breast Cancers / Z.Yamazaki et al. / p269～269
• General Lecture 81. Phase I Clinical Study of KRN 8602 / H.Majima / p269～269
• General Lecture 82. Phase I Study of CPT-11,a Derivative of Camptothecin / H.Furue et al. / p269～269
• General Lecture 83. Pharmacokinetics of CPT-11,a Newly Semisynthesized Anticancer Agent Camptotecin(CPT) / K.Morimoto et al. / p270～270
• General Lecture 84. Not Received / /
• General Lecture 85. Not Received / /
• General Lecture 86. Chemopreventive Effect of Antineoplaston A-10 on Urethane Induced Pulmonary Neoplasm in Mice / H.Yoshida et al. / p270～270
• General Lecture 87. Lysis of Leukemic Cells by Human Macrophages / M.Sasada et al. / p270～270
• General Lecture 88. Generation of Lymphokine-activated Killer Cells with Different Surface Phenotype by Cultivation with Recombinant Interleukin 2 and/or Recombinant Interferone γ or T-cell Growth Factor in Gastric Cancer Patients / S.Koyama et al. / p271～271
• General Lecture 89. The Function of Non-parenchymal Liver Cells(2nd Report)Enhancement of Cytotoxity of Pit Cells in Rat Liver by Interleukin 2 / A.Yamauchi et al. / p271～271
• General Lecture 90. Rapid Induction of Activated Killer Cells by PWM Conjugated Acrylate Beads(CMC-1) / S.Ohno et al. / p271～271
• General Lecture 92. Induction of Cytokines in Ascites of Patients with Ovarian Cancer by OK-432 and Ascitic Supernatant's Inhibition Effect on Colony Formation of Autologous Carcinoma Cells / N.Ito et al. / p272～272
• General Lecture 93. Induction of Cytokines in Ascites of Patients with Ovarian Cancer by OK-432 / H.Mori et al. / p272～272
• General Lecture 94. Augmentation of Interleukin-2 Receptor Expression of Peripheral Blood Lymphocytes Stimulated in vitro OK-432 / K.Hamagashira et al. / p272～272
• General Lecture 95. Effects of OK 432 On Interaction of Lymphocytes with Autologous Tumor Cells / A.Uchida et al. / p273～273
• General Lecture 96. Induction of Activated Killer Cells Challenged in vitro with Lentinan as Polysaccharides / M.Tani et al. / p273～273
• General Lecture 97. B.R.M-like Activities of Analogues to Eisenine,a Tripeptide Extracted from a Maline Alga,the So-called "Arame" / T.Kojima et al. / p273～273
• General Lecture 98. Anti-tumor Effect of Recombinant Human Lymphotoxin Derived from CHO Cells on a Tumor Line of Human Glioma / T.Mikami et al. / p274～274
• General Lecture 99. Anti-tumor Effect of Human Recombinant Tumor Necrosis Factor(Hu-rTNF)on Brain Tumor Cells / K.Sakamoto et al. / p274～274
• General Lecture 100. Antiproliferative Effect of rIFN-β,-γ and Medroxyprogesterone Acetate(MPA)on the Human Breast Cancer Cell Line ZR-75-1 / S.Shiiki et al. / p274～274
• General Lecture 101. Mechanism of the Synergism between nHuIFN-α,γ and nHuTNF-α,β in Cell Cycle Progression / M.Muro et al. / p275～275
• General Lecture 102. Not Received / /
• General Lecture 103. Protective Effect of Intracellular Glutathione against TNF Cytotoxicity / N.Yamauchi et al. / p275～275
• General Lecture 104. Study of Direct Anti-tumor Effect of r-Hu-TNF-α on Human Renal Cell Carcinomas Heterotransplanted in Nude Mice / K.Nakauchi et al. / p275～275
• General Lecture 105. Direct Anti-cancer Effect of OK-432,IFN-gamma and IFN-alpha aganist Human Urogenital Cancers Xenografted into Nude Mice / Y.Hosoya et al. / p276～276
• General Lecture 106. Antiproliferative Effects of Human Recombinant Tumor Necrosis Factor on Gynecologic Tumor Cells in vitro (Combined Effect with Interferons or Anticancer Drugs) / H.Kondo et al. / p276～276
• General Lecture 107. Study of UFT with Simultaneous Administration of Interferon Using Established Human Renal Cell Carcinoma Heterotransplanted into Nude Mice / H.Shirakawaet al. / p276～276
• General Lecture 108. Study of Radiotherapy with Smimultaneous Administration of Interferon Using Established Human Renal Cell Carcinoma Heterotransplanted into Nude Mice / H.Kurauchi et al. / p277～277
• General Lecture 109. Immunohistochemical Approach to Reveal the Cell Cycle of Uterine Cancer / M.Yoshinouchi et al. / p277～277
• General Lecture 110. Quantitative Nuclear DNA Analysis of Epitherial Ovarian Tumors / S.Hirata et al. / p277～277
• General Lecture 111. Morphological in Vestigations of TTK-2 Cell Line Derived from Normal Busal Decidual Tissue / K.Hashii et al. / p278～278
• General Lecture 112. Studies on the Neoplastic Transformation of the TTK-2 Cell Line Derived from Normal Human Decidua / I.Tateyama et al. / p278～278
• General Lecture 113. Immunohistological Study of Enhancement of MHC Antigen Expression by Interferon-gamma / T.Tanaka et al. / p278～278
• General Lecture 114. The Application of Laser Scanning Microscopy to Cell Biology (The Structure,Characteristics, and Basic Experiment) / M.Sugita et al. / p279～279
• General Lecture 115. DNA Ploidy Using Paraffin-embedded Materials in Urological Cancer / M.Yamamoto et al. / p279～279
• General Lecture 116. Study of Simultaneous Flow Cytometric BrdU/DNA Analysis with Urological Tumors / T.Shimabukuro et al. / p279～279
• General Lecture 117. Cell Cycle Kinetics of Human Prostate Cancer / K.Hattori et al. / p280～280
• General Lecture 118. Studies of Bladder Cancer by a Two-parameter DNA-RNA Microspectrophotometric Analysis / H.Yamamoto et al. / p280～280
• General Lecture 120. Analysis of Cell Cycle by BrdU Labeling Method Using Flow Cytometry / Y.Tsuji et al. / p280～280
• General Lecture 121. The Correlation of Expressing a Nuclear Antigen Reactive with Monoclonal Antibody Ki-67 with Degree of Malignancy in Gastric Cancer / T.Kamata et al. / p281～281
• General Lecture 122. Thymidine Kinase and Thynidylate Synthetase Activities in Human Gastric Cancer / Y.Kawachi et al. / p281～281
• General Lecture 123. Detection of the Growth Fractions in Colorectal Cancer by Monoclonal Antibody against DNA Polymerase α / A.Yamaguchi et al. / p281～281
• General Lecture 124. Flow Cytometric Analysis of DNA Histogram in Rectal Carcinoma / Y.Araki et al. / p282～282
• General Lecture 125. Expression of Carbohydrate Antigens on Leucocyte Surface Membranes / K.Orimo et al. / p282～282
• General Lecture 126. The Mode of Liver Metastasis and Survival Rate of the Patients with Liver Metastasis of Digestive Organ Cancer / S.Imaoka et al. / p282～282
• General Lecture 127. Treatment of Simultaneous Liver Metastasis from Colorectal Carcinoma / T.Utsunomiya et al. / p283～283
• General Lecture 128. Hepatic and Pulmonary Metastasis in Patients with Rectal Cancer Following the Curative Surgery / T.Sawada et al. / p283～283
• General Lecture 129. Clinicopathological Study of DNA Histogram Pattern and Liver Metastasis in Colorectal Carcinoma / K.Kurooka et al. / p283～283
• General Lecture 130. Expression of Cancer-associated Carbohydrate Antigens in Primarry Lesion and Liver Metastatic Lesion of Colorectal Cancer / Y.Arisawa et al. / p284～284
• General Lecture 131. Venous Invasion and Liver Metastasis of Colorectal Cancer in Immunohistochemistry of Laminin / R.Kubo et al. / p284～284
• General Lecture 132. Prevention of Liver Metastasis of Colonic Cancer by Portal Administration of ACNU-Lipiodol in Mice / J.Wakasugi et al. / p284～284
• General Lecture 133. Clinicopathological Study of Malignant Lesion in the Gastric Remnant / S.Ishii et al. / p285～285
• General Lecture 134. Clinicopathological Investigation of Early Gastric Cancer with Emphasis on the Fatal Factors / S.Tanaka et al. / p285～285
• General Lecture 135. Clinical Evaluation of the Area of Serosal Invasion in Gastric Cancer / H.Nishidoi et al. / p285～285
• General Lecture 136. Immunohistochemical Localization of Carbohydrate Antigen 19-9 in Gastric Cancer / N.Tanimoto et al. / p286～286
• General Lecture 137. Localization of CEA and CA19-9 in Well-differentiated Early Cancer,Atypical Epithleium and Ulcer of the Stomach / K.Kohfuji et al. / p286～286
• General Lecture 138. A Study of Localization of Fibronectin and Laminin in Human Gastric Cancer / T.Mukai et al. / p286～286
• General Lecture 139. Immunohistological Study of Laminin(LN)and Type IV Collagen(CIV)in Colorectal Cancer / J.Hida et al. / p287～287
• General Lecture 140. Not Received / /
• General Lecture 141. Cytokeratin Pattern in Bladder Cancer Immunohistochemical Investigation / M.Ueno et al. / p287～287
• General Lecture 142. Usefulness of the Presence of β-human Chorionic Gonadotfopin(β-HCG)in Bladder Tissue for Evaluation of Bladder Cancer / K.Fukunaga et al. / p287～287
• General Lecture 143. A Clinical Value of Urinary Cytology in Followup Cases of Bladder Tumor / K.Ebisui et al. / p288～288
• General Lecture 144. Clinical and Pathological Study of Prostatic Carcinoma / H.Koike et al. / p288～288
• General Lecture 145. Histological and Histochemical Analysis of Responsiveness of Prostatic Cancer to Various Therapies / N.Moriyama et al. / p288～288
• General Lecture 146. Results of Segmental and en bloc Resection for Urachal Carcinomas / T.Yamada et al. / p289～289
• General Lecture 147. Superficial Cancer Spread and its Regional Nodal Metastasis in Early Gastric Cancer / K.Uchida et al. / p289～289
• General Lecture 148. Evaluation of Gastric Cancer Resected Palliatively Because of Unresectable Lymph Node Metastasis / T.Nakadate / p289～289
• General Lecture 149. Retroperitoneal Lymph Node Metastasis and Intraperitoneal Spreading in Ovarian Cancer / T.Kasamatsu et al. / p290～290
• General Lecture 150. Investigation of Para-aortic Lymphnode Metastases in Gynecologic Cancers / M.Higashi et al. / p290～290
• General Lecture 151. Not Received / /
• General Lecture 152. Perivesical Micrometastasis of Bladder Carcinoma / Y.Hiraoka et al. / p290～290
• General Lecture 153. Clinicopathological Study of Distant Metastasis from the Carcinoma of the Head and Neck Origin / W.Nishijima et al. / p291～291
• General Lecture 154. The Incidence of Remote Metastasis Recurrence after Curative Operation of Differentiated Thyroid Cancer / S.Noguchi et al. / p291～291
• General Lecture 155. Mechanism of lung Metastasis from Colo-rectal Cancer / M.Kameyama et al. / p291～291
• General Lecture 156. A Retrospective Survey about Pulmonary Metastasis of Cervical Carcinoma / M.Takemura et al. / p292～292
• General Lecture 157. Neo-adjuvant Chemotherapy for Osteosarcoma-prognosis of the Cases with Pulmonary Metastasis / H.Shimizu et al. / p292～292
• General Lecture 158. Surgical Manipulation of VX2 Carcinoma in the Liver Evokes Enhancement of Metastasis in Rabbits / T.Nishizaki et al. / p292～292
• General Lecture 159. Histopathological Findings of the Endometrium on Peri-and/or Post-menopausal Uterine Bleedings / T.Kagabu et al. / p293～293
• General Lecture 160. Cytomofphological Features of Endometrial Hyperplasia / K.Yamauchi et al. / p293～293
• General Lecture 161. Endometrial Cancer in Young Women / H.Sawai et al. / p293～293
• General Lecture 162. Clinico-pathologic Study of Serous(Papillary)Adenocarcinoma of the Endometrium / Y.Hirai et al. / p294～294
• General Lecture 163. Study on Patho-histologic Findings and Clinical Course of Uterine Sarcoma / Y.Iizuka et al. / p294～294
• General Lecture 164. The Importance of Cytology Screening in Pregnant Women / M.Kamiwatari et al. / p294～294
• General Lecture 165. Cervical Conizationand Stage Ib Occult Carcinoma of the Uterine Cervix / M.Ikeuchi et al. / p295～295
• General Lecture 166. Clinicopathological Study on the Histological Types of Cervical Cancer / N.Yukimuraet al. / p295～295
• General Lecture 167. A Clinicopathological Study on Adno and Adenosquamous(mixed)Carcinoma of the Uterine Cervix / K.Ohmi et al. / p295～295
• General Lecture 168. A Case of Pregnancy Complicated with a Malignant Tumor of the Ovary / M.Okamoto et al. / p296～296
• General Lecture 169. A Clinicopathdogic Study for 19 Patients with Paget's Disease of the Vulva / S.Kodama et al. / p296～296
• General Lecture 170. Analysis on Metastatic Bone Tumors / Y.Kagami et al. / p296～296
• General Lecture 171. Not Received / /
• General Lecture 172. Clinical Study of Renal Cell Carcinoma with Bony Metastasis (Comparative Study with Lung Metastasis) / T.Onishi et al. / p297～297
• General Lecture 173. Combination Chemotherapy Combined with Surgical Resection for the Bladder Cancer Patients Presented with Bone Metastasis / S.Nomura et al. / p297～297
• General Lecture 174. Not Received / /
• General Lecture 175. Diagnosis and Treatment for the Skeletal Metastases of Cancer / K.Saotome et al. / p297～297
• General Lecture 176. A Clinical Study of Skull Metastases of Malignant Neoplasms / J.Onda et al. / p298～298
• General Lecture 177. Metastatic Melanoma in Brain-A Successful Case Treated DTIC / M.Kobayashi et al. / p298～298
• General Lecture 178. Brain Metastases in Patients with Breast Cancer / T.Tabei et al. / p298～298
• General Lecture 179. Clinical Study of Delayed Brain Metastasis from Small Cell Lung Cancer(SCLC) / N.Takifuji et al. / p299～299
• General Lecture 180. Treatment of Brain Metastases from Lung Cancer in the Aged Patients / R.Nishikawa et al. / p299～299
• General Lecture 181. Prostatic Carcinoma Metastatic to Choroid / D.Horiuchi et al. / p299～299
• General Lecture 182. Prognosis of Choriocarclnoma with Brain Metastasis / T.Imamura et al. / p300～300
• General Lecture 183. A Clinicopathological Study of Precancerous Condition of Oral Mucosa / T.Fukuda et al. / p300～300
• General Lecture 184. Pathological Examination of Biopsies in Mesopharyngeal Lesions in 271 Specimens / R.Shimizu et al. / p300～300
• General Lecture 185. Immunohistochemical Study of Head and Neck Cancers / J.Hirota et al. / p301～301
• General Lecture 186. Immunohistochemical Study of the Head and Neck Cancer / N.Hyo et al. / p301～301
• General Lecture 187. Histologic Evaluation of Seventy Cases of Gingival Carcinoma / M.Takita et al. / p301～301
• General Lecture 188. Clinicopathological Analysis of Transglottic Cancer / K.Umatani et al. / p302～302
• General Lecture 189. Immunohistochemical Localization of Intermediate-sized Filaments in Salivary Gland Tumors / R.Matsushima et al. / p302～302
• General Lecture 190. Positron Emission Tomography(PET)Imaging Using Labelled Amino Acids in Patients with Gliomas / K.Mineura et al. / p302～302
• General Lecture 191. Value of Gd-DTPA in MRI of Spinal Cord Tumors / K.Yoshida et al. / p303～303
• General Lecture 192. The Utility of Ultrasound in Metastatic Lymphnodes of Head and Neck Tumor / R.Nishimura et al. / p303～303
• General Lecture 193. CT Evaluation of Malignant Lymphoma of the Head and Neck / I.Yamada et al. / p303～303
• General Lecture 194. The Relationship between the Mitosis of Thyroid Cancer and the Thermographic Findings / H.Usuki et al. / p304～304
• General Lecture 195. Evaluation of Clinical Application of 31P-MRS to Presurgical Chemotherapy for Malignant Bone and Soft Tissue Tumors / T.Kojima et al. / p304～304
• General Lecture 196. Clinical Trend of Chemotherapy for Osteosarcoma / S.Yamawaki et al. / p304～304
• General Lecture 197. Studies on the Anticancer Drug Sensitivity Test against Human Ovarian Tumor--The Effect of Danazol / H.Chiba et al. / p305～305
• General Lecture 198. Fundamental Studies of Subrenal Capsule Assay--Drug Administration under Immunosuppfessed Condition / K.Ushijima et al. / p305～305
• General Lecture 199. Subrenal Capsule Assay in Gynecological Malignancies for Oral Adjuvant Chemotherapy / I.Sekiguchi et al. / p305～305
• General Lecture 200. Correlation between the Results from Snbrenal Capsule Assay and the Clinical Responses in the Gynecological Malignancies / N.Kamiya et al. / p306～306
• General Lecture 201. Investigation of Relationships between Predictive Testing of Uterine Cancer to UFT by Subrenal Capsule Assay and by Inhibition of Thymidylate Synthase and Levels of 5-Fu in Tumor Tissues / M.Suzuki et al. / p306～306
• General Lecture 202. Predictive Tesring of Choriocarcinoma to Chemotherapy by the Subrenal Capsule Assay / M.Ogiao et al. / p306～306
• General Lecture 203. Human Tumor Clonogenic Assay for Gynecologic Cancers / H.Fujita et al. / p307～307
• General Lecture 204. Not Received / /
• General Lecture 205. Drug Sensitivity of Four Established Choriocarcinoma Cell Lines and the Clinical Courses of Their Original Patients / S.Goto et al. / p307～307
• General Lecture 206. Not Received / /
• General Lecture 207. Clinical Application of in vitro Drug Sensitivity Test for Osteosarcoma / J.Kakizaki et al. / p307～307
• General Lecture 208. Evaluation of Additive Effect on Anti-cancer Agents by Mouse Sarcomas--By"Intra Test-tube Contact to Drugs and Subcutaneous Inoculation Method" / O.Inoue et al. / p308～308
• General Lecture 209. Transrectal Ultrasonography for Cervical Cancer / T.Nagano et al. / p308～308
• General Lecture 210. CT Findings and Prognosis of Cervix Carcinoma / N.Narimatsu et al. / p308～308
• General Lecture 211. Evaluation of Myometrial Invasion by Endometrial Carcinoma Using Transvaginal Sonography / I.Honda et al. / p309～309
• General Lecture 212. Not Received / /
• General Lecture 213. The Application of Magnetic Resonance Imaging(MRI)to Endometrial Carcinoma / M.Yamasaki et al. / p309～309
• General Lecture 214. MRI of Uterine Malignancies / H.Kaneko et al. / p309～309
• General Lecture 215. Correlation of Computed Tomography and Serum Tumor Markers in Follow-up and Evalua-tion of Patients with Recurrent Ovarian Cancer / Y. Wakabayashi et al. / p310～310
• General Lecture 216. Assessment of Magnetic Resonance Imaging in Diagnosis and Treatment of Ovarian Tumor / M. Kawamura et al. / p310～310
• General Lecture 217. ¹³¹I-monoclonal Antibody OC-125 F (ab') for Diagnostic Injection / M. Nagashima et al. / p310～310
• General Lecture 218. Quantitative Analysis of Digital Substraction Angiography in Invasive Mole / M. Ohashi et al. / p311～311
• General Lecture 219. Clinical Evaluation of Lung Perfusion Scintigraphy for Renal Cell Carcinoma with Venous Thrombosis / H. Shiraiwa et al. / p311～311
• General Lecture 220. Not Received / /
• General Lecture 221. A Study of Photon Counting Imaging of Hematoporphyrin Derivative (HpD) Fluorescence for Bladder Cancer Detection / T. Misaki et al. / p311～311
• General Lecture 222. A Study of Surbrenal Capsule Assay with Immuno Suppressive Agents against Esophageal Cancer / M. Terashima et al. / p312～312
• General Lecture 223. Evaluation of Subrenal Capsule Assay Using BDF1 Mice with Cyclosporin A to Gastrointesti-nal Cancer / T.Satta et al. / p312～312
• General Lecture 224. Study of the Effect of Anticancer Drugs on the DNA Histogram of Tumor Cell in vivo / T. Kosaka et al. / p312～312
• General Lecture 225. Experimental and Clinical Study on Tumor Heterogeneity of DNA Contents and Chemosen-sitivities / T.Shimomatsuya et al. / p313～313
• General Lecture 226. The Importance of Histological Study in Subrenal Capsule Assay / H.Anzai et al. / p313～313
• General Lecture 227. Chemosensitivity Test by SRCA for Liver Cancer Specimens Obtained by Fine Needle / H.Fukushima et al. / p313～313
• General Lecture 228. Not Received / /
• General Lecture 229. The Evaluation of Chemosensitivity Test for Esophageal Cancer by ATP Assay Using Endoscopic Biopsy / K.Kawano et al. / p314～314
• General Lecture 230. In vitro Human Tumor Chemosensitivity Testing Based on Intracellular ATP Levels(Human Tumor ATP Assay) / M.Miura et al. / p314～314
• General Lecture 231. An Experimental Study for Anticancer Agent Sensitivity Test in Human Gastric Cancer Cell Lines by Flow Cytometry / N.Katayanagi et al. / p314～314
• General Lecture 232. Simplified Scintillation Assay for Chemosensitivity Testing of Malignant Effusion / T.Wada et al. / p315～315
• General Lecture 233. Chemosensitivity of Human Anaplastic Thyroid Carcinoma Serially Transplanted into Unde Mice / A.Yoshida et al. / p315～315
• General Lecture 234. Study of Ultrasonic Examination in the Diagnosis of Breast Cancer / T.Koida et al. / p315～315
• General Lecture 235. Ultrasonographic Detection of Metastatic Axillary Lymph Nodes in Breast Cancer / M.Nishida et al. / p316～316
• General Lecture 236. Not Received / /
• General Lecture 237. Successful Imaging of Lung Cancers by a Radiolabeled Monoclonal Antibody / T.Okabe et al. / p316～316
• General Lecture 238. Experimental Study of Tumor Detection Using¹³¹Labeled F(ab')₂ Fragments of Monoclonal Antibodies to CA 19-9 and CEA(IMACIS-1) / N.Mitsuhashi et al. / p316～316
• General Lecture 239. Clinical Evaluation of Immunoscintigraphy Useing IMACIS-1 / T.Takahashi et al. / p317～317
• General Lecture 240. Radioimmunoscintigraphy of Malignant Tumors Using a Cocktail of F(ab')₂ Fragments of Monoclonal Antibodies to CEA and CA19-9 with I-131(IMACIS-1) / A.Okazaki et al. / p317～317
• General Lecture 241. Not Received / /
• General Lecture 242. Daiagnosis of Depth Invasion in Gastric Cancer by Examination of Endoscopic Ultrasonography(EUS)and Operative Ultrasonography(OUS) / H.Hasegawa et al. / p317～317
• General Lecture 243. The Evaluation of Angiography in Diagnosing the Peritoneal Dissemination of Gastrointesti- nal Cancer / Y.Shioaki et al. / p318～318
• General Lecture 244. Preoperative Examinations for Esophageal and Rectal Cancer by MRI / T.Tsuda et al. / p318～318
• General Lecture 245. Evaluation of the Effect of Lipiodol-associated Transcatheter Arterial Embolization(LpTAE)for Hepatocellular Carcinoma by Hepatic Angiography / M.Itsubo et al. / p318～318
• General Lecture 246. Evaluation of the Continuous Intra-arterial Infusion Treatment for Hepatic Cancer by DSA / Y.Furukawa et al. / p319～318
• General Lecture 247. Growth Rate of Small Hepatocellular Carcinoma by Computed Tomography / T.Sato et al. / p319～319
• General Lecture 248. Subrenal Capsule Assay(SRC)Using Human Lung Cancer Xenograft and Tumor Tissues from Lung Cancer Patients / A.Tada et al. / p319～319
• General Lecture 249. Chemosensitivity Test for Platinum Derivatives Using a Subrenal Capsule Assay / S.Kudoh et al. / p320～320
• General Lecture 250. Analysis of the Chemo and Endocrine Sensitivity Test by Subrenal Capsule Assay for Breast Cancer / S.Kawamura et al. / p320～320
• General Lecture 251. Preclinical Evaluation of a New Anthracycline Derivative, SM-5887 on the Subrenal Capsule Assay / H.Shibata et al. / p320～320
• General Lecture 252. The Subrenal Capsule Assay(SRCA)as a Predictor of Tumor Response to Chemotherapy in Rats / E.Yokoyama et al. / p321～321
• General Lecture 253. The Combination Effect of Caffeine and CDDP on Human Lung Cancer Cell Line / Y.Ohsaki et al. / p321～321
• General Lecture 254. Not Received / /
• General Lecture 255. A Study of the Effects of Anti-tumor Agents Combined with γ-interferon on an Established Cell Line of Human Maxillary Carcinoma and Human Tumor Xenografts Transplanted into Nude Mice / M.Miyata et al. / p321～321
• General Lecture 256. Postoperative Adjuvant Chemotherapy for Advanced Gastric Cancer Based on the Succinate Dehydrogenase Inhibition (SDI) Test / T.Kusumoto et al. / p322～322
• General Lecture 257. The Investigation of the Evaluable Rate in Succinate Dehydrogenase Inhibition Test(SDI Test)for in vitro Chemosensitivity Test / Y.Kirihara et al. / p322～322
• General Lecture 258. Studies of Cell Killing Effects of PDT Using Adriamycin and Hematoporphyrin Derivative on Cultured Human Bladder Cancer Cells,KK-47 / M.Nitta et al. / p322～322
• General Lecture 259. MTT Assay as a Chemosensitivity Test / A.Suto et al. / p323～323
• General Lecture 260. Clinical Evaluation of Cisplatin(CDDP)for Malignant Glioma / T.Hotta et al. / p323～323
• General Lecture 261. Effect of Chemotherapy Combined ACNU and VP-16 / K.Nomura et al. / p323～323
• General Lecture 262. Effectiveness of Combination Therapy with Cisplatin and Etoposide for Malignant Brain Tumors / J.Yoshida et al. / p324～324
• General Lecture 263. Combination Chemotherapy with Cyclophosphamide(C),Vincristine(V)and Dacarbazine(D)in Patients with Malignant Pheochromocytoma / T.Tsuchihashi et al. / p324～324
• General Lecture 264. An effective Combination Chemotherapy(P-CAV)for Advanced Skin Cancer / S.Yanagawa et al. / p324～324
• General Lecture 265 Clinico-pathological Studies on Effects of Induction Chemotherapy in Squamous Cell Carcinoma of Gingiva / H.Sunakawa et al. / p325～325
• General Lecture 266. Chemotherapy of Head and Neck Squamous Cell Cancer / M.Uchida et al. / p325～325
• General Lecture 267. Combination Chemotherapy with Cisplatin,Peplomycin and Methotrexate(CPM)for Advanced Head and Neck Carcinoma / I.Tsushin.i et ai. / p325～325
• General Lecture 268. Combination Chemotherapy with Adriamycin,Cisplatin and Peplomycin on Head and Neck Cancer / H.Hosoda et al. / p326～326
• General Lecture 269. Multi-drug Combination Therapy of Cancer of the Head and Neck Using Cisplatin as the Basic Agent / T.Furusaka et al. / p326～326
• General Lecture 270. A study on Multi-drug Combination Chemotherapy Including Cisplatin(CDDP)in Cancer of Head and Neck / T.Takaoka et al. / p326～326
• General Lecture 271. Non-cross-resistance in the Chemotherapy of Head and Neck Cancer / M.Toji et al. / p327～327
• General Lecture 272. Not Received / /
• General Lecture 273. Treatment of Squamous Cell Carcinoma of the Head and Neck(H&N)Using Combination Chemotherapy with Vincristine(VCR), Methotrexate(MTX),Bleomycin(BLM)and Mitomycin-C(MMC),"BOMM" / N.Kohno et al. / p327～327
• General Lecture 274. A Study of Second Line Chemotherapy for CDDP-PEP Combination Therapy / M.Kawaura et al. / p327～327
• General Lecture 275. Sequential MTX/5FU Therapy for Advanced Gastric Cancer / T.Konishi et al. / p328～328
• General Lecture 276. Methotrexate-5-fluorouracil-leucovorin Therapy in Patients with Advanced Gastric Cancer / Y.Ono et al. / p328～328
• General Lecture 277. Sequential Methotrexate• 5FU Therapy for Advanced Gastric Cancer / M.Kitamura et al. / p328～328
• General Lecture 278. Combination Therapy of CDDP and MTX.5-FU Sequential Therapy for Gastroenteral Cancers / S.Ohyama et al. / p329～329
• General Lecture 279. Sequential Methotrexate and 5-fluorouracil for Advanced Colorectal Cancer / S.Yasuda et al. / p329～329
• General Lecture 280. Joint Study on Chemoendocrine Therapy for Gastric Cancer of the Borrmann IV Type in the Tochigi Prefecture,Japan / K.Kanazawa / p329～329
• General Lecture 281. Randamized-controlled Study of Treatment with UFT-MMC or UFT-ACR for Advanced Gastric Cancer / J.Satoh et al. / p330～330
• General Lecture 282. Not Received / /
• General Lecture 283. A 4-year Surviving Case of Borrmann 2 Gastric Cancer Remarkably Improved by MF(Mitomycin C and 5-FU)Therapy / Y.Watanabe et al. / p330～330
• General Lecture 284. A Case of Unresectable Gastric Cancer for which a Regimen Containing Lentinan,Mytomycin C and Tegafur was very Effective / A.Sano et al. / p330～330
• General Lecture 285. A Multi-Institutional Study on Postoperative Adjuvant Chemotherapy for Cancer of the Stomach / S.Arima et al. / p331～331
• General Lecture 286. Adjuvant Mitomycin-C(MMC)Prolongs Survival Time of Patients Undergoing Curative Surgery for Stage IV Gastric Cancer / D.Korenaga et al. / p331～331
• General Lecture 287. Study of Post-operative Immunochemotherapy in Gastric Cancer / S.Sato et al. / p331～331
• General Lecture 288. Postoperative Adjubant Chemotherapy for Gastric Cancer / T.Yamada et al. / p332～332
• General Lecture 289. Study on the Period of Postoperative Chemotherapy for Gastric Cancer / S.Suzuki et al. / p332～332
• General Lecture 290. 29pmN A Study of Postoperative Adjuvant Chemotherapy Using UFT in Cases who Had Undergone Curative Resection for Gastric Cancer / T.Kitoh et al. / p332～332
• General Lecture 291. Postoperative Adjuvant Chemotherapy with NCS(Neocarzinostatin)and 5FU for Treatment of Gastric Cancer / T.Yokomori et al. / p333～333
• General Lecture 292. Randomized Controlled Study between 5'-DFUR+ACNU and 5'-DFUR+ACNU+MMC in Advanced Gastric Cancer / E.Fukuyama et al. / p333～333
• General Lecture 293. Combination Chemotherapy with UFT• Etoposide• CDDP• Adriamycin(FEPA)in Advanced Gastric Cancer / M.Hayakawa et al. / p333～333
• General Lecture 294. Chemotherapy of Advanced Gastric Cancer--UFT-M vs UFT/CDDP / H.Nagai et al. / p334～334
• General Lecture 295. A Phase II Study of 5 days Continuous Infusion of 5-FU against Advanced Gastric Cancer / K.Miyamoto et al. / p334～334
• General Lecture 296. Experimental and Clincal Study of 5-fluorouracil-high Dose Leucovorin Combination / T.Sasaki et al. / p334～334
• General Lecture 297. The Remarkable Effects of Immunochemotherapy by FT207 Added to OK 432 for the End stage of Gastric Cancer
• A Case Report / M.Kiriyama et al. / p335～335
• General Lecture 298. Influence of Gastrectomy on Absorption of Oral Pyrimidine Fluoride / T.Sato et al. / p335～335
• General Lecture 299. Cytochrome P-450 and Postoperative Chemotherapy in Gastric Cancer / H.Watanabe et al. / p335～335
• General Lecture 300. Effect of Angiotensin II-Induced Hypertension Chemotherapy against Recurrent and Advanced Gastric Cancer in Senile Patients / M.Satoh et al. / p336～336
• General Lecture 301. Clinical and Pathohistological Patterns of Improvement in Advanced Gastric Carcinoma after AngiotensinII induced Hypertension Chemotherapy(IHC) / H.Sato et al. / p336～336
• General Lecture 302. Effect of Angiotensin II-Induced Hypertension Chemotherapy in Advanced Pancreatic Cancer / M.Kimura et al. / p336～336
• General Lecture 303. Hypertension Two-route Chemotherapy for Human Intraperitoneal Cancer / R.Abe et al. / p337～337
• General Lecture 304. Holter Monitoring of Patient Receiving Induced Hypertension Chemotherapy / K.Okuma et al. / p337～337
• General Lecture 305. Inhibition of Thymidylate Synthase in Lung Cancer Tissue after Administration of UFT / H.Wada et al. / p337～337
• General Lecture 306. dTMP Synthase Activity in Cancer Cells / Y.Hashimoto et al. / p338～338
• General Lecture 307. Study of Thymidylate Synthase Inhibitory Rate(TSIR)after Oral Treatment of Gastric Cancer Patients with 5-Fu / K.Namatame et al. / p338～338
• General Lecture 308. Study on the Pharmacokinetics of UFT in the Hepatocellular Carcinoma Patients Associated with Cirrhosis / Y.Une et al. / p338～338
• General Lecture 309. Not Received / /
• General Lecture 310. Results of Combination Chemotherapy for Advanced Urothelial Cancer / S.Komatsubara et al. / p339～339
• General Lecture 311. Results of M-VAC(Methotrexate,Vinblastine,Doxorubicin and Cisplatin) for Advanced Carcinoma of the Urothelium / M.Igawa et al. / p339～339
• General Lecture 312. Experience of M-VAC Chemotherapy for Cancer of the Urogenital Tract / S.Sai et al. / p339～339
• General Lecture 313. The Combination Chemotherapy of MTX, VBL, ADM and CDDP for Advanced Urothelial Cancer / T.Takeuchi et al. / p340～340
• General Lecture 314. Clinical Evaluation of M-VAC Chemotherapy for Advanced Urothelial Cancer / S.Kameyama et al. / p340～340
• General Lecture 315. Not Received / /
• General Lecture 316. Treatment of Advanced Bladder Cancer / T.Ushiyama et al. / p340～340
• General Lecture 317. Clinical Study on Effectiveness of Combination Chemotherapy with CDDP for Ovarian Cancer / A.Takahashi et al. / p341～341
• General Lecture 318. Prognosis of Ovarian Cancer Treated with or without Cl. splatin(CDDP) / N.Usui et al. / p341～341
• General Lecture 319. Not Received / /
• General Lecture 320. Second-line Chemotherapy for Recurrent Ovarian Cancers Primarily Treated with Cyclophos-phamide,Adriamycin and Cisplatine(CAP) / H.Yokota et al. / p341～341
• General Lecture 321. The Treatment of far Advanced Cancer Patients with Massive Ascites / M.Hirono et al. / p342～342
• General Lecture 322. Clinical Studies on the Efficacy Of Maintenance Chemotherapy for Patients with Ovarian Cancer / K.Takakuwa et al. / p342～342
• General Lecture 323. A Study of 49 Ovarian Cancer Patients Administered CDDP-ip / M.Maruyama et al. / p342～342
• General Lecture 324. Effect of Intraperitorieal Administration of CDDP,Anticoagulatory,Antiplasmin and Anti-thrombinIII on Recurrent Ovarian Cancer / H.Suzuki et al. / p343～343
• General Lecture 325. Effects of Remission Induction Chemotherapy on Blood Coagulability in Patients with Gynecological Malignancies / K.Sawaguchi et al. / p343～343
• General Lecture 326. Blood Coagulability Changes in Patients with Advanced Gynecological Malignancies under Remission Induction Chemotherapy / K.Tomiura et al. / p343～343
• General Lecture 327. Evaluation of Total Parenteral Nutrition(TPN)Using Imbalanced Aminoacids Solution in Chemotherapy for Ovarian Cancer / M.Sato et al. / p344～344
• General Lecture 328. Clinical Evaluation of Adjuvant Postoperative Chemotherapy following Radical Hysterectomy for Carcinoma of the Uterine Cervix / N.Matsuo et al. / p344～344
• General Lecture 329. Adjuvant Chemotherapy for Uterine Cervical Cancer by Cooperative Group Study(II) Cooperative Study Group of Chemotherapy for Gynecological Cancer / H.Sugimori / p344～344
• General Lecture 330. Adjuvant Chemotherapy and Radiotherapy in Patients with Cervical Cancer at High Risk Recurrent Group after Radical Hystrectomy(Pilot study) / H.Dozono et al. / p345～345
• General Lecture 331. Cisplatin,Ifosfamide and Doxorubicin Chemotherapy for Recurrent Cervical Cancer of the Uterus / T.Arimatsu et al. / p345～345
• General Lecture 332. A Study of Continuous Peplomycin Infusion Therapy in Progressive Recurrent Gynecological Cancer / A.Uematsu et al. / p345～345
• General Lecture 333. Effects Use of the PAE Method to stage III Ovarian Embryonal Carcinoma / K.Murayama et al. / p346～346
• General Lecture 334. Efficancy of Regimen Containing CDDP on Ovarian Malignant Mixed Mesodermal Tumor / S.Hino et al. / p346～346
• General Lecture 335. Promising Results of Cisplatin,Ifosfamide and Doxorubicin for Grade 3 Endometrial Cancer / T.Matsuzaki et al. / p346～346
• General Lecture 336. Combined Chemotherapy with CDDP and Vindesine for Uterine Cervical Adenocarcinoma and Endometrial Carcinoma / Y.Ihara et al. / p347～347
• General Lecture 337. Efficacy of Adjuvant Chemotherapy by CDDP on Uterine Sarcoma / J.Nishida et al. / p347～347
• General Lecture 338. A Successful Case with High-dose Cisplatinum for Adenocarcinoma of the Vulva / A.Arakawa et al. / p347～347
• General Lecture 339. Effect of High-dose Chemotherapy with Autologous Bone Marrow Transplantation in Malignant Ovarian Tumor / M.Murakami et al. / p348～348
• General Lecture 340. High dose Chemotherapy and Autologous Bone Marrow Transplantation for Advanced Testicular Cancer / H.Ishii et al. / p348～348
• General Lecture 341. High dose Chemotherapy with Autologous Bone Marrow Transplant for Patient with Advanced Testicular Cancer / N.Deguchi et al. / p348～348
• General Lecture 342. High-dose Chemotherapy Supported by Autologous Bone Marrow Transplantation in Advanced Cancers / M.Kasai et al. / p349～349
• General Lecture 343. Review on Efficacy of Autologous Bone Marrow Transplantation for Bone Marrow Depression after High Dose Chemotherapy / S.Tsuchiya et al. / p349～349
• General Lecture 344. Supportive Therapy of Cancer Chemotherapy with Use of Peripheral Blood Stem Cell Transplantation / K.Sampi et al. / p349～349
• General Lecture 345. Effectiveness of Ubenimex in Preventing Bone Marrow Suppression Caused by Chemotherapy / K.Komuta et al. / p350～350
• General Lecture 346. A Combination Therapy of PSK and Cephalantin for the MDS Patients / Y.Kobayashi et al. / p350～350
• General Lecture 347. Effects of Cepharanthin on Chemotherapy-induced Leukopenia / K.Asukai et al. / p350～350
• General Lecture 348. Restorative Effect of Muroctasin,MDP-Lys(L-18),on Leukopenia by Anticancer Chemother-apy in Lung Cancer--Comparative Study by Envelop Method / M.Takada et al. / p351～351
• General Lecture 349. The Recoverable Effect of Lentinus Edodes(LNT)from Granulocytopenia after Chemotherapy for Gynecologic Malignancies / S.Takeshita et al. / p351～351
• General Lecture 350. Stimulatory Effect of Glycyrrhizin on CFU-C Colony Formation from Human Bone Marrow Cells in vitro / F.Omori et al. / p351～351
• General Lecture 351. Phase I/II Study of KRN 8601(Recombinant Human Granulocyte Colony Stimulating Factor,rhG-CSF)in the Combination Chemotherapy for Malignant Lung Tumours / H.Kunitoh et al. / p352～352
• General Lecture 352. Effect of Combined Therapy with Sizofiran(SPG)and Irradiation on Patients with Cervical Cancer / M.Ohno et al. / p352～352
• General Lecture 353. Not Received / /
• General Lecture 354. Changes in Lymphocyte Subsets and ADCC/NK Activities by Immunopotentiators(SPG,OK-432)in the Patients with Advanced Cervical Cancer / K.Hasegawa et al. / p352～352
• General Lecture 355. Effects of Schizophyllan(SPG)on Immunological Parameters in Patients with Cervical Cancer during Radiotherapy / H.Yabushita et al. / p353～353
• General Lecture 356. Effects of Combined Therapy with Sizofilan(SPG)and Irradiation on Cervical Cancer Patients / T.Imai et al. / p353～353
• General Lecture 357. The Immunological Effect of Concomitant Use of Schizophyllan(SPG)on Advanced Uterine Cervical Cancer Treated with Radiation / O.Iwanari et al. / p353～353
• General Lecture 358. Activation of Human Macrophage by SPG Injected Intramusclary / J.Tung Chen et al. / p354～354
• General Lecture 359. Clinical Evaluation of Postoperative Adjuvant Immunochemotherapy with Sizofiran(SPG)for Resectable Gastric Cancer: A Randomized controlled study / S.Fujimoto et al. / p354～354
• General Lecture 360. Clinical Evaluation of the Antitumor Polysaccharide SIZOFIRAN(SPG)in Advanced Gastric Cancer / I.Nakao et al. / p354～354
• General Lecture 361. An immunological Study of Anti-tumor Polysaccharide(SPG:Sonifilan) for Oral Cancer by Two-color Analysis / S.Kikuchi et al. / p355～355
• General Lecture 362. Effect of SPG for Neutrophilic Function / T.Nakayama et al. / p355～355
• General Lecture 363. Immunotherapy of Terminal-stage Malignant Tumor with an Immunopotentiator Lentinan / S.Yagi et al. / p355～355
• General Lecture 364. Immunological Evaluation of Intrapleural and/or Intraperitoneal Lentinan Therapy for Carcinomatous Pleuritis and Peritonitis / S.Yoshino et al. / p356～356
• General Lecture 365. Nutritional Supplementation of Elemental Diet and Immunochemotherapy with Lentinan in 4 Cases / O.Soeda et al. / p356～356
• General Lecture 366. Change of Blood Lentinan Level in Long Term Course / Y.Yajima et al. / p356～356
• General Lecture 367. Successful Therapy with Tegafur and Lentinan for Hepatocellular Carcinoma--A Case Report / K.Miyamoto et al / p357～357
• General Lecture 368. Evaluation of BRM Therapy on Immunostatus in Patients with Head and Neck Cancer / T.Yoshida et al. / p357～357
• General Lecture 369. Augmentation of Natural Killer(NK)Activity and Prevention of Chemotherapy-induced Leukocytopenia by Lentinan / H.Shimizu et al. / p357～357
• General Lecture 370. The Influence of Lentinan on Postoperative Cellular Immunosupression in Gastric Cancer / T.Momiyama et al. / p358～358
• General Lecture 371. Endoscopic Local Injection of Lentinan in the Patients with Gastric Cancer / K.Morise et al. / p358～358
• General Lecture 372. A Study of Immunotherapy in Advanced Agers' Gastric Cancer(Part 1) / T.Gotoh et al. / p358～358
• General Lecture 373. Influence of Peritumoral Injection of Lentinan on the Local and Systemic Lymphocytic Subsets in Patients with Gastric Cancer / Y.Obi et al. / p359～359
• General Lecture 374. Effect of Administration of Lentinan on Rabbit IgG Binding Fc-receptor of Monocytes in Patients with Gastric Cancer / T.Kitahora et al. / p359～359
• General Lecture 375. Effect of Lentinan on Natural Killer Activities in Patients with Gastric Carcinoma at Early stage / H.Yamanishi et al. / p359～359
• General Lecture 376. Clinical and Pathological Review of Malignant Lymphoma at Autopsy / Y.Tamaki et al. / p360～360
• General Lecture 377. Two Cases of Primary Orbital Malignant Lymphoma / M.Kojima et al. / p360～360
• General Lecture 378. A Case Report of the Gastric Malignant Lymphoma with Early Gastric Cancer / A.Takeda et al. / p360～360
• General Lecture 379. Clinical Features of AILD as a Prelymphomatous Lesion / T.Kobayashi et al. / p361～361
• General Lecture 380. Polymorphic Reticulosis of the Larynx Diagnosesed as T Cell Lymphoma by Autopsied Laryngeal Specimen / T.Nakashima et al. / p361～361
• General Lecture 381. Two Cases of Thyroid Medullary Carcinoma / H.Nishino et al. / p361～361
• General Lecture 382. Clinical Study on Malignant Transformed Papilloma / M.Ida et al. / p362～362
• General Lecture 383. Study of a Case with Cancerization in the Gastric Atypical Epithelial Lesion / M.Eriguchi et al. / p362～362
• General Lecture 384. A 37-year-Old Man with Primary Carcinoma Jejunum / T.Hattori et al. / p362～362
• General Lecture 385. A Case of Hepatocelluar Carcinoma(HCC)within Adenomatous Hyperplasia in Liver / T.Urushihara et al. / p363～363
• General Lecture 386. Application of Endoscopic Retrograde Bile Drainage(ERBD)and Lenthinan to the Treat-ment of the Cancer in Common Hepatic Bile Duct Accompanied by the Anomolous Arrangement of the Pancreatico Biliary Ductal System / A.Murakami et al. / p363～363
• General Lecture 387. Examination of Adrenocortical Carcinoma Experienced by Our Department / H.Nozaki et al. / p363～363
• General Lecture 388. Cases detected by Neuroblastoma Mass Screening Test in Our Department / K.Sue et al. / p364～364
• General Lecture 389. Four Cases of Oral Cancer which Followed Unusual Clinical Courses / B.Satake et al. / p364～364
• General Lecture 390. Basic Study on Excimer Dye Laser in Gynecology / T.Sugishita et al. / p364～364
• General Lecture 391. Improvement of the Operative Technique in Laser Vaporization Therapy of Cervical Intraepithelial Neoplasia / H.Kanou et al. / p365～365
• General Lecture 392. Contact Nd. YAG Laser Treatment for early Cervical Neoplasia--Significance of Preoperative Diagnosis and Countermeasures against Incomplete Excision / K.Kitsuki et al. / p365～365
• General Lecture 393. The Study on Residual Lesion after CO2 Laser Conization for Cervical Intraepiterial Neoplasia / J.Miyako et al. / p365～365
• General Lecture 394. Integral Laser-phtodynamic Treatment of Bladder Tumors Using Hematoporphyrin Derivative / K.Naito et al. / p366～366
• General Lecture 395. Combination of Photoradiation Therapy with Chemotherapy Using Adriamycin for Advanced Breast Cancer / H.Hirakawa et al. / p366～366
• General Lecture 396. The Effectiveness of Photodynamic Therapy(PDT)with Hematoporhyrin Derivative(HpD)for Roentgenographically Occult lung Cancer / K.Furuse et al. / p366～366
• General Lecture 397. Clinical Evaluation of Direct Current Therapy with Chemotherapy in Lesional Treatment of Malignant Tumors / Y.Matsushima et al. / p367～367
• General Lecture 398. The Evaluation of the Effect of High Energy Shock Wave on Tumor / K.Kohri et al. / p367～367
• General Lecture 399. Enhancement of Cell Killing Effect of Ultrasound by Photosensitizer / K.Umemuta et al. / p367～367
• General Lecture 400. Cytotoxic Effects of Photoexcited TiO2 Semiconductor Colloid on Human Cancer Cells / M.Masuda et al. / p368～368
• General Lecture 401. Studies on Laserthermia and Photodynamic Therapy(PDT)Using Nd:YAG Laser / H.Tsunekawa et al. / p368～368
• General Lecture 402. Immunohistochemical Study of Ras p21 in Gastric Cancer / K.Sugiyama et al. / p368～368
• General Lecture 403. Expression of Oncogenes in Colorectal Cancer / N.Hara et al. / p369～369
• General Lecture 404. Immunohistochemical Evaluation of Ras and Myc Oncogene Expression in Ovarian Carcinomas / H.Matsuda et al. / p369～369
• General Lecture 405. Detection of Human Papillomavirus(HPV)DNA and E₆/E₇mRNA in the Precancerous Lesions of Uterine Cervix / N.Nagai et al. / p369～369
• General Lecture 406. Relations between the Follow up Results of Cervical Dysplasia and Immunohistochemical Findings on Human Papilloma Virus(HPV)Infection / M.Sato et al. / p370～370
• General Lecture 407. Clinical Evaluation of Presence of EGF Receptors(EGFR)in Human Esophageal Carcinomas / G.Shirozu et al. / p370～370
• General Lecture 408. EGF and EGFR status in Borrmann 4 type Gastric Carcinoma / S.Fushida et al. / p370～370
• General Lecture 409. Investigation of the Precancerous Lesion of the Thyroid Tumors Using EGF-R / H.Masuda et al. / p371～371
• General Lecture 410. Anti-tumor Effect of EGF(Epidermal growth factor)on Human Breast Cancer Transplanted in Nude Mice / Y.Murayama et al. / p371～371
• General Lecture 411. Emergence of Epidermal Growth Factor and Its Receptor in Endometrial Carcinoma under the Influence of Progestin / Y.Yokoyama et al. / p371～371
• General Lecture 412. Clinical Study on EGF Concentration in Urine and Tissue EGF Receptor in Patients with Bladder Cancer / T.Fujioka et al. / p372～372
• General Lecture 413. Effect of Epidermal Growth Factor(EGF)on the Growth of Squamous Cell Carcinoma of Bladder(SCaB) / T.Hattori et al. / p372～372
• General Lecture 414. An Evaluation of Neck Dissection in Tongue Cancer / S.Makino et al. / p372～372
• General Lecture 415. Clinical Evaluation of Radical Neck Dissection in Oral Squamous Cell Carcinoma / S.Okabe et al. / p373～373
• General Lecture 416. Investigation on Patients Undergoing Neck Dissection at Our Clinic / N.Akazawa et al. / p373～373
• General Lecture 417. Clinical Study of the Patients who Underwent Enucleation or Partial Resection for Thyroid Cancer / M.Fujimori et al. / p373～373
• General Lecture 418. Not Received / /
• General Lecture 419. Pathological Studies on Rectal Cancer Treated with Preoperative Irradiation and Anticancered Suppositary / J.Itoh et al. / p374～374
• General Lecture 420. Preoperative Combined Therapy for Rectal Cancer by Radiation and 5-Fluorouracil Suppository / M.Niwa et al. / p374～374
• General Lecture 421. Pre-and Intra-operative Radiotherapy for rrctal Cancer--Clinical Evaluation of Its Complications / Y.Otashiro et al. / p374～374
• General Lecture 422. High-dose-rate Afterloading Intracavitary Irradiation and Expandable Biliary Endoprosthesis for Malignant Biliary Obstruction / H.Yoshimura et al. / p375～375
• General Lecture 423. Chemotherapy with Chest Radiotherapy in Limited Disease of Small Cell Lung Carcinoma / T.Soejima et al. / p375～375
• General Lecture 424. Combined Treatment of Radiation and Chemotherapy for Lung Cancers / K.Ono et al. / p375～375
• General Lecture 425. Clinical Study on Radiosensitization of Aclarubincin / T.Miyamoto et al. / p376～376
• General Lecture 426. Clinical Application of MFD(Multiple Fractions Per Day)for Non-oat Cell Carcinoma of the Lung / Y.Kikuchi et al. / p376～376
• General Lecture 427. The Prognosis According to New Clinical TNM Staging of Lung Cancer Treated with Radiation Therapy / K.Hayaakawa et al. / p376～376
• General Lecture 428. Characrerization of the Long Cancer Patients who Received Radiation Therapy and Survived for a Long Time--Special Reference to the Analysis of Peripheral Blood Lymphocyte Subsets and Tumor Infiltrated Lymphocytes / T.Inomata et al. / p377～377
• General Lecture 429. Study of Prognostic Factors fbr Patients with Limited Non-small Cell Lung Cancer / K.Yonezawa et al. / p377～377
• General Lecture 430. Conservative Treatment for Early Breast Cancer--Study at T.W.M.C / M.Kitaet al. / p377～377
• General Lecture 431. Significance of Postoperative Radiotherapy for Breast Cancer / T.Yanagisawa et al. / p378～378
• General Lecture 432. The Effectiveness of Radiation Therapy for Bone Metastasis from Breast Cancer / M.Kawashima et al. / p378～378
• General Lecture 433. Radiation Therapy for Metastatic Bone Tumors / Y.Nagata et al. / p378～378
• General Lecture 434. The Effect of Radioiodine Treatment for Thyroid Carcinoma with Tracheal Invasion / M.Katagiri et al. / p379～379
• General Lecture 435. Radiotherapy for the Tracheo-bronchial Recurrence of the Esophageal Cancer after Surgery / T.Ogino et al. / p379～379
• General Lecture 436. The Combined Treatment of Radiation and Cisplatin for Esophageal Cancer / A.Takamura et al. / p379～379
• General Lecture 437. Combination Therapy with Radiation and CDDP for Carcinoma of Esophagus Results of Clinical in 40 Radiation Facieities in Japan / T.Ishiskawa et al. / p380～380
• General Lecture 438. Multi-axis and Over Centerable Conformation Radiotherapy for Esophageal Cancer / T.Mamiya et al. / p380～380
• General Lecture 439. Application of Multiple Fractions per Day(MFD)to Esophageal Carcinoma / S.Nishino et al. / p380～380
• General Lecture 440. High-dose-rate Intracavitary Irradiation for Esophageal Carcinoma Combined with External Irradiation / H.Fukuda et al. / p381～381
• General Lecture 441. Clinical Experience with Intraoperative Radiotherapy in Cases of Esophageal Carcinoma / Y.Ozawa et al. / p381～381
• General Lecture 442. Not Received / /
• General Lecture 443. Anti-tumor Effects of Intraperitoneal Injection of Recombinant Interleukin 2 / K.Shiiba et al. / p381～381
• General Lecture 444. Prediction of Effect of Immunotherapy of Cancer and Its Clinical Correlation / K.Takahashi et al. / p382～381
• General Lecture 445. A Clinical Trial of Lentinan and Interleukin-2 Combination Therapy in the Treatment of Primary Hepatocellular Carcinoma Patients / H.Matsuda et al. / p382～382
• General Lecture 446. Not Received / /
• General Lecture 447. Phase II Study of Combination Therapy with rIL2 and IFN-beta / T.Tamura et al. / p382～382
• General Lecture 448. Clinical Evaluation of Intrapleural Adoministation of IL-2 for the Patients Diagnosed as Pleuritis Carcinomatosa / M.Negishi et al. / p383～383
• General Lecture 449. Enhancement of Cytotoxic Activity of Mediastinal Lymphnodes by Trans-tracheal Injection to the Subcarinal Lymphnode of Recombinant Interleukin-2(rIL-2) / K.Tani et al. / p383～383
• General Lecture 450. The Immunological Modulation of Malignant Lymphoma Patients by Interferon-α / H.Yamaue et al. / p383～383
• General Lecture 451. Effect of Intraperitoneally Administered OK 432 Followed by Intraperitoneal rIL-2(Recombinant Interleukin 2)on Peritonitis Carcinomatosa / Y.Kanaoka et al. / p384～384
• General Lecture 452. Postoperative Adjuvant Therapy of Renal Cell Carcinoma with α-interferon (Preliminary Report) / Y.Satomi et al. / p384～384
• General Lecture 453. Clinical Study of Interferon-α Therapy for Patients with Advanced Renal Cell Carcinoma / T.Murai et al. / p384～384
• General Lecture 454. Effect of AS Vaccinia Virus for Advanced Cancer / T.Matsui et al. / p385～385
• General Lecture 455. Study on Immuno-competence of Peripheral Blood and Regional Lymph Nodes in Patients with Breast Cancer--Influence of Preoperative Adminisration of Immuno-Activators / H.Takahashi et al. / p385～385
• General Lecture 456. Clinical Effect of PSK on Esophageal Cancer as an Immunopotentiator (Second Report) / K.Ogoshi et al. / p385～385
• General Lecture 457. An Adjuvant Immunochemotherapy for Gastric Cancer / A.Koike et al. / p386～386
• General Lecture 458. Serum Immunosuppressive Substance(IS)and Effects of Biological Response Modifier,PSK on Urogenital Tumors / K.Ikeda et al. / p386～386
• General Lecture 459. Study on Evaluation of Immunochemotherapy to Prevent the Recurrence of Bladder Cancer / Y.Nakagami et al. / p386～386
• General Lecture 460. Evaluation of Postoperative Immunochemotherapy(VCR,MMC,MTX)for Lung Cancer Patients / T.Ikeda et al. / p387～387
• General Lecture 461. Clinical Evaluation of the Postoperative Immunochemotherapy for Gastric Cancer / M.Shiraishi et al. / p387～387
• General Lecture 462. Evaluation of Immuno-chemotherapy for Non-curative,Non-resectable Gastric Cancer Patients / Y.Kondoet al. / p387～387
• General Lecture 463. Evaluation of Immuno-chemotherapy for Non-curative and Non-resectable Colorectal Cancer / O.Nishida et al. / p388～388
• General Lecture 464. Clinical and Experimental Study on Oral Administration of "OK-432" / M.Abe et al. / p388～388
• General Lecture 465. Controlled Trial of Postoperative Adjuvant Chemotherapy with OK-432 for Advanced Colorectal Cancer / Y.Horita et al. / p388～388
• General Lecture 466. The Study of the Optimal Therapeutic Protocol of OK-432 by Sequential Kinetics of the Various Immunological Parameter / S.Fujieda et al. / p389～389
• General Lecture 467. Immunoactivity of Patients with Hepatoma Injected OK-432:Comparison between These with Splenic Arterial Injection and Systemic Venous Injection / T¡Hihara et al. / p389～389
• General Lecture 468. Immunotherapy of Terminal-stage Malignant Tumors with an Immunopotentiator OK-432 and Lentinan / Y.Yagi et al. / p389～389
• General Lecture 469. 3 Case of Cervical Cancer with Long Survival(More than 5 yrs)by Administration of OK-432 / R.Nakamura et al. / p390～390
• General Lecture 470. A Study of the Immunoactivity of Ovarian Cancer Patients with or without OK 432 Treatment / S.Itoh et al. / p390～390
• General Lecture 471. A Case of Ovarian Cancer Induced to Complete Remission by i.p.Injection of OK-432 and Chemotherapy / H.Kato et al. / p390～390
• General Lecture 472. Immunological Effects of OK 432 Administration in Cervical Cancer Patients--Suppressor T Cell(CD8₊₊11₊),Killer T Cell(CD8₊₊1₋)and Con.A.induced Suppressor Cell Activity / M.Mizuno et al. / p391～391
• General Lecture 473. Induction of Tumor Necrosis Factor(TNF)and Interferon-γ(IFN一γ)by OK-432 in Renal Cancer Patients / K.Kumagai et al. / p391～391
• General Lecture 474. Effect of OK 432 on Advanced Gastric Cancer / M.Fujii et al. / p391～391
• General Lecture 475. Effect of Preoperative Intra-tumoral Injection of OK-432 to Gastric Cancer(The 2nd Report) / A.Gohchi et al. / p392～392
• General Lecture 476. Combination Chemoimmunotherapy with MMC and OK 432 for Gastric Carcinoma / S.Arinaga et al. / p392～392
• General Lecture 477. Study of Postoperative Su-PS Skin Reaction in Pacients with Gastric Cancer With Special Reference to the Relation with Prognosis / T.Ogawaet al. / p392～392
• General Lecture 478. Effect of OK-432 on the Cellular Immunological Competence of Patients with Stomach Cancer / T.Hirose et al. / p393～393
• General Lecture 479. Not Received / /
• General Lecture 480. Augmentation of Immunological Reactivities of Regional Lymph Node Lymphocytes by OK-432 in Gastric Cancer Patients:Comparison between the Effects of Intratumoral Injection and Those of Oral Administration / EYanagawa et al. / p393～393
• General Lecture 481. Preventive Effect of Bithmus Subnitrate on Toxicity by CDDP / M.Ogawara et al. / p393～393
• General Lecture 483. Bismuth Subnitrate, Clinical Studies for Reducing Effects on Cisplatin Toxicities / T.Morikawa et al. / p394～394
• General Lecture 484. The Effect of Bismuth Subnitrate for Pharmacokinetics and Side Reactions of Cisplatin in Patients of Gynecological Cancer / H.Hirayama et al. / p394～394
• General Lecture 485. Side Effects of High Dose Cisplatin / M.Sakugawa et al. / p394～394
• General Lecture 486. Effects of Carboplatin on the Renal Function / Y.Yasui et al. / p395～395
• General Lecture 487. Clinical Studies of CDDP Nephrotoxicity--Comparison with Intravenous,Intra-arterial and Intra-peritoneal Methods / E.Ito et al. / p395～395
• General Lecture 488. Renal Tubular Damage Associated with Cisplatin Nephrotoxicity / K.Higuchi et al. / p395～395
• General Lecture 489. Intraperitoneal Chemotherapeutic Perfusion(IPCP)with Mitomycin C and Intraperitoneal Administration(IP)of the Carcinostatic Cocktail Including Cisplatin for Ovarial Cancer(O-C)--Clinical Study of Renal Failure after IPCP-IP Method / S.Yamashita et al. / p396～396
• General Lecture 490. Effects of the Combined Use of Cisplatin(CDDP)and Ifosfamide(IFX)on Tubular Toxicity / A.Fujita et al. / p396～396
• General Lecture 491. Prevention of Frey's Syndrome with an Island Temporalis Fascial Flap--A Preliminary Report / T.Kaneko et al. / p396～396
• General Lecture 492. The Reconstruction of 80 Head and Neck Cancer Patients with Free Rectus Abdominis Musculocutaneous Flaps / H.Asato et al. / p397～397
• General Lecture 493. Not Received / /
• General Lecture 494. Operative Therapy for Advanced or Recurrent Breast Cancer--Especially Using Pedicled Omental Flap and Mesh Skin Grafting / M.Yoshioka et al. / p397～397
• General Lecture 495. Surgical Result of the Modified Radical Mastectomy(Auchincloss)for T2-breast Cancer / S.Oura et al. / p397～397
• General Lecture 496. Reconstruction of Malignant Bone Tumor by Composite Graft of Biomaterial(Almina Ceramic/Dacron Fabric) / K.Shinjo et al. / p398～398
• General Lecture 497. Urinary Diversion via a Continent Urinary Reservoir:Comparison between Indiana Pouch and Kock Pouch / Y.Okada et al. / p398～398
• General Lecture 498. Anterior Pelvic Exentration with Vulvectomy for Advanced Female Urethral Carcinoma / T.Ito et al. / p398～398
• General Lecture 499. Trial of the Preservation of the Bladder Function Following Radical Hysterectomy Using Neurostain and Functional Electric Stimulation / T.Hachisuga et al. / p399～399
• General Lecture 500. Relationship of Operative Method of Rectal Cancer to Postoperative Urinary and Sexual Function / H.Naito et al. / p399～399
• General Lecture 501. Male Sexual Function after Autonomic Nerve Preserving Operation for Rectal Cancer / K.Eguchi et al. / p399～399
• General Lecture 502. Amelioration of Combination Chemotherapy with Cisplatin: Escalation of Total Dose and Improvement of Quality of Life in Patients with Ovarial Malignant Tumor / S.Isonishi et al. / p400～400
• General Lecture 503. A Study of Evaluation of Side Effects in CAP Chemotherapy.--Cardiotoxicity Evaluated by Radionuclide LVEF and Ototoxicity by Audiogram / M.Yabuta et al. / p400～400
• General Lecture 504. Complications of VAC Therapy / K.Sutou et al. / p400～400
• General Lecture 505. Clinical Analysis on Side Effects of Maintenance Chemotherapy against Gynecological Malignant Tumors / T.Shimoda et al. / p401～401
• General Lecture 506. A Case of Hypomagnesia and Refractory Cardiac Arrythmia Associated with Cisplatin Combination Therapy / H.Murata et al. / p401～401
• General Lecture 507. Urinary β₂-microglobulin as Indicator of Impaired Excretion of Methotrexate / K.Amino et al. / p401～401
• General Lecture 508. Anosmia Caused by Long-term Administration of Tegaful / K.Toda et al. / p402～402
• General Lecture 509. Not Received / /
• General Lecture 510. Double Blind Study on Preventive Efficacy of Mesna against Ifosfamide(IFO)Induced Urinary Disorders / M.Fukuoka et al. / p402～402
• General Lecture 511. Clinical Efficacies of Mepitiostane as a Supportive Therapy in Chemotherapy for Breast and Lung Cancer / H.Yokoi et al. / p402～402
• General Lecture 512. Prevention of Adriamycin-induced Alopecia by Scalp Hypothermia with a Deep-frozen Duncool-Cap / Y.Konishi et al. / p403～403
• General Lecture 513. A Study of Septicemia in Cancer Patients / N.Tanabe et al. / p403～403
• General Lecture 514. Immunostimulating Effect and Tumor Growth Inhibitory Effect of Panax Ginseng / M.Katano et al. / p403～403
• General Lecture 515. Cancer Chemotherapy with Oriental Medicine(Second) / A.Sato et al. / p404～404
• General Lecture 516. Role of Fine Needle Aspiration Cytology in Diagnosis of Breast Cancer / K.Hisamatsu et al. / p404～404
• General Lecture 517. Clinical Studies on Diagnosis of Aspiration Cytology, Mammography and Ultrasound for Breast Carcinoma / H.Fukushima et al. / p404～404
• General Lecture 518. In vivo Measurement of Electrical Bio-impedance of Breast Tumors / Y.Konishi et al. / p405～405
• General Lecture 519. The Annual Trend and Problem Seen in the Mas Examination for the Breast Cancer / J.Amano et al. / p405～405
• General Lecture 520. Mass Screening for Breast Cancer--The Results for 8 Years and Further Problems / T.Ishida et al. / p405～405
• General Lecture 521. Mass Screening for Breast Cancer / J.Ota et al. / p406～406
• General Lecture 522. The Mass Screening Campaign for Breast Cancer in Yokohama City, and the Study of Its Risk Factor / H.Yokoyama et al. / p406～406
• General Lecture 523. Diagnosis and Treatment of Pre-cancer of stage of Esophagus / H.Makuuchi et al. / p406～406
• General Lecture 524. The Study of Gastric Cancer Stroma on Biopsy / Y.Sonoda et al. / p407～407
• General Lecture 525. Mass Screening for Colorectal Cancer by an Immunological Fecal Occult Blood Test / Y.Kumanishi et al. / p407～407
• General Lecture 526. Not Received / /
• General Lecture 527. Precancerous Lesions of Primary Hepatic Cancer:Its Diagnosis and Treatment / A.Harada et al. / p407～407
• General Lecture 528. Diagnosis and Treatment for Precancerous Lesion of the Vocal Cord / G.Mizojiri et al. / p408～408
• General Lecture 529. Experimental Evaluation of Adriamycin-containing Poly-L-lactic Acid Microspheres for P815 Tumor Cells / O.Ike et al. / p408～408
• General Lecture 530. Antitumoric Effects with Sustained Release Implants of Anti-cancer Drugs / K.Matsumura et al. / p408～408
• General Lecture 531. Experimental Study of Cisplatin-lipiodol Emulsion / Y.Hasegawa et al. / p409～409
• General Lecture 532. Study of a Chemotherapeutic Method for Esophageal Cancer Enhanced Antitumor Effect of Peplomycin by Lipid-surfactant Mixed Micelles and a Macromolecular Dextran Sulfate / D.Kuroda et al. / p409～409
• General Lecture 533. Transportation of MMC to Lymph-system by Means of Activated Charcoal / K.Ito et al. / p409～409
• General Lecture 534. CDDP Chemotherapy in Combination with AngiotensinII Pressor for DMBA-induced Primary Ovarian Carcinoma / H.Higashijima et al. / p410～410
• General Lecture 535. Not Received / /
• General Lecture 536. ADM Bladder Instillation Therapy for Superficial Bladder Tumors / S.Nakagawa et al. / p410～410
• General Lecture 537. Early Intravesical Instillation of Adriamycin(ADM)with Oral Administration of 5-fluorouracil(5-FU)after Transurethral Resection(TUR)for Superficial Bladder Cancer / T.Ueda et al. / p410～410
• General Lecture 538. Evaluation of Prophylactic Intravesical Chemotherapy for Superficial Bladder Cancer Using Hazard Analysis / H.Akaza et al. / p411～411
• General Lecture 539. Prophylactic Intravesical Instillation Therapy with Adriamycin and Mitomycin C in Patients with Superficial Bladder Cancer / J.Yoshimoto et al. / p411～411
• General Lecture 540. Intravesical Instillation Therapy of Pepleomycin and Mitomycin C for Superficial Bladder Cancer / N.Sakakibara et al. / p411～411
• General Lecture 541. Prophylactic Intravesical Chemotherapy in Patients with Superficial Bladder Tumors / H.Ito et al. / p412～412
• General Lecture 542. Prophylactic Use of Mitomycin C Bladder Instillation for Preventing the Recurrence of Bladder Tumours / T.Mishina et al. / p412～412
• General Lecture 543. Regional Hyperthermia in the Treatment of Uterine Cervical Cancer / M.Kinugasa et al. / p412～412
• General Lecture 544. Treatment Results of Radiotherapy Combined with Hyperthermia Using 8MHz RF for the Advanced and Recurrent Cancer of the Uterine Cervix / Y.Ito et al. / p413～413
• General Lecture 545. Case Reports:Remarkable Effect of Hyperthermia Combined with Irradiation on Metastatic Tumor of Uterine Cervical Cancer / J.Fujimoto et al. / p413～413
• General Lecture 546. The Usefulness of Hyperthermia in the Cancer Treatment, Especially the Deep Hyperthermia for Gynecological Malignancies / Y.Kobashi et al. / p413～413
• General Lecture 547. Clinical Effect of Hyperthermochemotherapy on Cervical and Ovarian Malignancies / M.Iwata et al. / p414～414
• General Lecture 548. Clinical Results of Hyperthermic Therapy to Superficial and Deep Seated Tumor with BSD 1000 System / K.Hatano et al. / p414～414
• General Lecture 549. Clinical Effects of Hyperthermia Treatment for Bladder Cancer / K.Ueda et al. / p414～414
• General Lecture 550. Prostatic Hyperthermia by Using an Intraluminal Applicator / M.Hirai et al. / p415～415
• General Lecture 551. Eight MHz RF-hyperthermia for Deep-seated Urological Malignancies / K.Nakajima et al. / p415～415
• General Lecture 552. Studies of PPD and Su-PS Skin Tests and Lymphocyte Subsets in Patients with Advanced Urological Malignancies Treated with Hyperthermia / A.Nishino et al. / p415～415
• General Lecture 553. Anti-Tumor Effect and Change of the Cell Cycle Treated by Hyperthermia and IFN Therapy (Fundamental and Clinical Studies) / M.Tada et al. / p416～416
• General Lecture 554. Synergistic Effects of Hyperthermia and CDDP on Invasive Bladder Carcinoma in Mice / R.Noguchi et al. / p416～416
• General Lecture 555. Not Received / /
• General Lecture 556. The Effect of Intraperitoneal Lavage with MMC and OK-432 i.p Administration at Surgery for Peritoneal Dissemination of Advanced Gastric Cancer / T.Fujimoto et al. / p416～416
• General Lecture 557. Topical Administration of Mitomycin C-dextran Conjugate(MMC-D)in Advanced Cancer Patients / K.Honda et al. / p417～417
• General Lecture 558. Experimental and Clinical Evaluation of Local Treatment with Anticancer Drug-oil Suspension (Nimustine-Lipiodol Suspension) / S.Kobayashi et al. / p417～417
• General Lecture 559. Percutaneous Intratumoral Injection Therapy of Lipiodol Containing Anticancer Drug / H.Aikawa et al. / p417～417
• General Lecture 560. Therapy for Small Hepatocellular Carcinoma Using Intratumoral Injection of Apatite-Adriamycin Solution / A.Saito et al. / p418～418
• General Lecture 561. Intrathecal Administration of ACNU fox Subarachnoid Dissemination of Malignant Tumor / M.Kochi et al. / p418～418
• General Lecture 562. Intrathoracic Injection Therapy with Cisplatin(CDDP)-fibrinogen(FBG)for Cancerous Pleurisy / S.Takanashi et al. / p418～418
• General Lecture 563. A New Therapy for Patients with Serious Pleuritis Carcinomatosa--Bio-Adhesio-Chemo(BAC)Therapy / K.Kawahara et al. / p419～419
• General Lecture 564. Treatment of Advanced Ascitic Ovarian Cancer with Cyclophosphamide,Adriamycin and Intraperitoneal Cisplatin / H.Taniguchi et al. / p419～419
• General Lecture 565. Intraperitoneal Infusion Chemotherapy Using Implanted Reservoir to Advanced Ovarian Cancer / T.Yoshida et al. / p419～419
• General Lecture 566. Topical CDDP Injection Therapy for Gynecologic Malignant Tumors which do not Allow Curative Excision / S.Sato et al. / p420～420
• General Lecture 567. Not Received / /
• General Lecture 568. Chemoembolization and Regional Hyperthermia with DSM(Degradable Starch Microspheres)in the Treatment of Malignant Hepatic Tumors / H.Ichikawa et al. / p420～420
• General Lecture 569. Local Hyperthermai for Carcinoma of the Bile Duct / K.Uchiyama et al. / p420～420
• General Lecture 570. Radio-hyperthermia for Pancreas Cancer / N.Hino et al. / p421～421
• General Lecture 571. Intraoperatvie RF Capacitive Hyperthermia for Unresectable Pancreatic Cancer / I.Hashida et al. / p421～421
• General Lecture 572. Blood Flow Evaluation Using the Thermal Clearance Curve / K.Sugimoto et al. / p421～421
• General Lecture 573. Therapeutic Results of Local Hyperthermia for Patients with Peritoneal Metastases of Gastric Cancer (CHPP and RF Heating) / Y.Inoue et al. / p422～422
• General Lecture 574. Clinical Evaluation of Intraperitoneal Hyperthermic Perfusion(IPHP)for Advanced Gastric Cancer / R.D.Shrestha et al. / p422～422
• General Lecture 575. Continuous Hyperthermic Peritoneal Perfusion with Cisplatin and Mitomycin C for Peritoneal Dissemination in Gastric Cancers / T.Fujimura et al. / p422～422
• General Lecture 576. Efficacy of Continuous Hyperthermic Peritoneal Perfusion(CHPP)with Whole Body Hypothermia on Survival Rate of Advanced Gastric Cancer / Y.Masuda et al. / p423～423
• General Lecture 577. Not Received / /
• General Lecture 578. Evaluation of the Efficacy of Hyperthermia Combined with Misonidazole from a Standpoint of Tumor Tissue Blood Flow(TbF) / K.Kobayashi et al. / p423～423
• General Lecture 579.Hyperthermochemotherapy Using a Thermosensitizer and ACNU / M.Kokubun et al. / p423～423
• General Lecture 580. Subsets of T Lymphocytes in Patients with Cancer in the Female Genital Organ Analysis Using Two Color Flow Cytometry / K.Miyazaki et al. / p424～424
• General Lecture 581. Production of Interferon-y in Peripheral Blood Mononuclear Cells in Patients with Uterine Cervical Cancer / T.Hanabayashi et al. / p424～424
• General Lecture 582. Production of Interferon-y and Effect of Its Production by Monocyte in Gynecological Cancer / S.Yamagiwa et al. / p424～424
• General Lecture 583. Killer T Cell Activity Specific to Epstein-Barr Virus in Patients with Carcinoma of Female Genital Tract / Y.Kitano et al. / p425～425
• General Lecture 584. Study of Lymphocyte Subset Infiltrated into the Endometrial Cancer Tissue / H.Noguchi et al. / p425～425
• General Lecture 585. Anti-tumor Activity in Regional Lymph Nodes of the Patients with Genito-urinary Tract Cancer / M.Yamashita et al. / p425～425
• General Lecture 586. Peripheral Lymphocyte Subsets in Therapy Resistance stage D Prostatic Cancer Patients / J.Suwata et al. / p426～426
• General Lecture 587. Studies on Splenectomy for Gastric Cancer Patients in Terms of Cellular Immunity / H.Yamagishi et al. / p426～426
• General Lecture 588. A Study for the Significance of Splenectomy in Surgery for Gastric Cancer I. The Effects of Splenectomy on Survival Rate and Immunological Parameters / T.Toge et al. / p426～426
• General Lecture 589. Clinical Evaluation of Splenectomy in stage 4 Gastric Cancer Patients / K.Iwata et al. / p427～427
• General Lecture 590. Not Received / /
• General Lecture 591. Effect of Blood Transfusions on Prognosis of Stomach Cancer / A.Kawaguchi et al. / p427～427
• General Lecture 592. Not Received / /
• General Lecture 593. Enhancement of Tumor Growth by Blood Transfusions / N.Takeuchi et al. / p427～427
• General Lecture 594. Hyperthermia for Malignant Glioma by Radiofrequency Capacitive Heating Using Different Sized Applicators / H.Hondo et al. / p428～428
• General Lecture 595. Interstitial Hyperthermia of Brain Tumor by Implant Heating System / T.Kobayashi et al. / p428～428
• General Lecture 596. Effect of Combined Treatment by Magnetic Induction Hyperthermia Using Ferromagnetic Implants and Chemotherapy(ACNU)
• Experimental Study on Rabbit Brain Tumor Model / K.Hattori et al. / p428～428
• General Lecture 597. Not Received / /
• General Lecture 598. Not Received / /
• General Lecture 599. Clinical Experience in Hyperthermia for Head and Neck Cancers / S.Umino et al. / p429～429
• General Lecture 600. Clinical Result of Advanced Esophageal Carcinoma Treated with Hyperthermia / I.Yamashita et al. / p429～429
• General Lecture 601. Two Cases of Malignant Tumor Treated with a Combination of Regional Hyperthermia and Chemotherapy / A.Kishi et al. / p429～429
• General Lecture 602. Multidisciplinary Treatment with Combined Hyperthermia,Chemotherapy and Radiotherapy for Postoperative Management or Treatment of Recurrent Gastrointestinal Tract Malig-nancies / M.Endow et al. / p430～430
• General Lecture 603. Hyperthermia Therapy Used Thermotron RF8 for Bone Mets or Bone Inverted Lesions of Malignant Tumors / N.Muta et al. / p430～430
• General Lecture 604. Application of Human Tumor Clonogenic Assay in Thermochemotherapy / A.Murakami et al. / p430～430
• General Lecture 605. Potentiation Mechanism of the Cytotoxic Effect of FT-207 by Hyperthermia / M.Miyake et al. / p431～431
• General Lecture 606. Rapid Hyperthermic Sensitivity Test Using Contact-sensitive Plates of Confluent Balb/c 3T3 Cell Monolayers / H.Matsuoka et al. / p431～431
• General Lecture 607. Evaluation of the Immunological Dynamics and Nutrition on Patients with Cancer of Digestive Organ / K.Sato et al. / p431～431
• General Lecture 608. Analysis of Cellular Immunity of Peritoneal Exudate Cells(PECs)and Peripheral Blood Cells in Patients with Early Gastric Cancer / T.Miyama et al. / p432～432
• General Lecture 609. Immunological Analyses of Gastric and Colorectal Cancer Patients with High LAK Activity / Y.Korosu et al. / p432～432
• General Lecture 610. ATPase Activity in Granulocytes from Patients with Carcinomas of the Gastro-intestinal Tract(GI Carcinoma) / T.Taniguchi et al. / p432～432
• General Lecture 611. Behavior of Peripheral granulocytes in Cancer Patients(The 2nd Report) / H.Ubukata et al. / p433～433
• General Lecture 612. Evaluation of in vitro PGE₂ Production in Human Peripheral Mononuclear Cells(PMC)Derived from Healthy Subjects and Patients with Cancer / M.Terada et al. / p433～433
• General Lecture 613. The Relationship between Soluble Factors by Peripheral Blood Mononuclear Cells and Glucocorticoids Levels of Cancer Patients / K.Ito et al. / p433～433
• General Lecture 614. Analysis of Immunocompetent Cells of Cancer Patients Treated with Anticancer Drugs / Y.Mitachi et al. / p434～434
• General Lecture 615. Evaluation of the Immunological Dynamics on Patients with Cancer of Digestive Organs / M.Kinjo et al. / p434～434
• General Lecture 616. Spleen Lymphocyte Subsets of Patients with Gastric Cancer--Analysis by Two Color Flow Cytemetry / M.Takahashi et al. / p434～434
• General Lecture 617. Studies on Subsets of Lymphocytes in Peripheral Blood and Splenic Venous Blood in Patients with Gastric Cancer by Using Two-color Flow Cytometry / A.Takagane et al. / p435～435
• General Lecture 618. Changes in Lymphocyte Subsets with Postoperative Chemotherapy(UFT,CPM)for Breast Carcinoma--A Comparative Study Using Two Colour Analysis / M.Kimura et al. / p435～435
• General Lecture 619. Usefulness of Su-PS Skin Reaction in Patients with Resected Lung Cancer / A.Ogasawara et al. / p435～435
• General Lecture 620. Autologous Mixed Lymphocyte Reaction(AMLR)in the Peripheral Blood and Spleen of Gastric Cancer Patients / M.Iwahashi et al. / p436～436
• General Lecture 621. The Importance of Examination into the Combined Effect of Hyperthermia and Chemother-apy by Using Contact-sensitive Plate(CSP) / K.Yano et al. / p436～436
• General Lecture 622. Effects of Hyperthermia on DNA Synthesizing Enzymes in Bone Marrow Cells in Patients with Acute Leukemia / H.Kudo et al. / p436～436
• General Lecture 623. The Experimental Study of Laserthermia for the Human Gastric Cancer Transplanted to the Nude Mice / H.Narumi et al. / p437～437
• General Lecture 624. Enhancement of Antitumor Effect of Antitumor Drugs by Hyperthermia in vitro / Y.Sakaguchi et al. / p437～437
• General Lecture 625. Enhancement of Antitumor Effect of Immunotherapy Combined with Hyperthermia / K.Mise et al. / p437～437
• General Lecture 626. Experimental Study of Local Hyperthermic Chemotherapy with Angiotensin-II for Malignant Bone Tumor(Part II) / F.Kinoshita et al. / p438～438
• General Lecture 627. Feasibility of Total-body Hyperthermia by Whole Abdominal Hyperthermia Using RF Capacitive Hyperthermia System / R.Harnazoe et al. / p438～438
• General Lecture 628. Comparison of Combined Effects of CDDP,OK-432 and Mild Systemic Hyperthermia in Two Ascites Tumor-host Systems / K.Komatsu et al. / p438～438
• General Lecture 629. Thermal Enhancement Effects of TMF and VDS / I.Tsukiyama et al. / p439～439
• General Lecture 630. Change in Heart Rate of Mice under Systemic Hyperthermia and Its Modification / W.Nakamura et al. / p439～439
• General Lecture 631. Results of Chemohyperthermia via Intraperitoneal Irrigation on Disseminated Peritoneal VX2 Carcinoma in Rabbits / H.Yasuda et al. / p439～439
• General Lecture 632. Selective Hyperthermia to Deep-seated Tumors Using Ferromagnetic Particles as a Target on the Rabbit Hepatic VX2-carcinomas / M.Hase et al. / p440～440
• General Lecture 633. Studies on High Frequency Inductive Heating by Liposomal Ferromagnetic Particles / S.Suzuki et al. / p440～440
• General Lecture 634. Effect of Hyperthermia on Lipid Peroxidation(LPO)and Superoxide Dismutase(SOD)in Experimental Liver Tumor / K.Suzuki et al. / p440～440
• General Lecture 635. A Phase II Trial with Cisplatin, Vindesine and Bleomycin for Esophageal Cancer / N.Mizunuma et al. / p441～441
• General Lecture 636. Clinical Evaluation of Postoperative Aggressive Chemotherapy for Thoracic Esophageal Cancer Patients who Underwent Curative Resection of Primary Lesion / K.Hirayama et al. / p441～441
• General Lecture 637. Clinical Evaluation of Combination Chemo-radiotherapy Including CDDP for Esophageal Cancer / K.Ikeda et al. / p441～441
• General Lecture 638. Combination Therapy Using Irradiation, CDDP and VDS for Lymph Node Recurrence of Esophageal Cancer / K.Okuyama et al. / p442～442
• General Lecture 639. Evaluation of Efficacy of CDDP for Hepatocellular Carcinoma / M.Tanei et al. / p442～442
• General Lecture 640. Phase II Study of Cisplatin for Hepatocellular Carcinoma / Y.Shirnada et al. / p442～442
• General Lecture 641. Clinical Trial of Intravenous Mitoxantrone in Patients with Advanced Hepatocellular Carcinoma / T.Yoshida et al. / p443～443
• General Lecture 642. DNA Alkyltransferase Activity in Human Cancer Tissue and Selective Cure of Deficient Tumor with ACNU / G.Isowa et al. / p443～443
• General Lecture 643. Effect of MQF-OK and MQF-OK-UFT Therapy for Advanced Gall Bladder Cancer and Bile Duct Cancer / Y.Tamura et al. / p443～443
• General Lecture 644. Results of Chemotherapy for Unresectable Pancreatic Carcinoma / T.Isawa et al. / p444～444
• General Lecture 645. Adjuvant Chemotherapy with Mitomycin C(MMC)and Tegafur (FT) after Surgical Resection of Colorectal Carcinoma A Preliminary Report / S.Kodaira et al. / p444～444
• General Lecture 646. Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Carcinoma(Second Report)3-year Survival after Surgery / K.Kunitomo et al. / p444～444
• General Lecture 647. A Multi-Institutional Study on Pre- and Postoperative Adjuvant Chemotherapy for Colorectal Cancer / K.Futami et al. / p445～445
• General Lecture 648. Not Received / /
• General Lecture 649. The Study on Pre and Post Operative Adjuvant Chemotherapy for Colorectal Cancer (Part 1) -The Concentration of the Drug in Tissues Following Administrated UFT / T.Shimoyama et al. / p445～445
• General Lecture 650. Clinical Evaluation of Postoperative Adjuvant Chemotherapy for Rectal Carcinoma / H.Ishikawa et al. / p445～445
• General Lecture 651. A Randomized Controlled Trial Comparing Short-term MF Chemotherapy with MF plus Long-term HCFU Chemotherapy as an Adjuvant to Curative Resection of Stomach Cancer / H.Nakazato et al. / p446～446
• General Lecture 652. Prospective Adjuvant Therapy of Carmofur(HCFU)plus OK-432 for stage III,IV Stomach Cancer(The First Report)Mifurol Study Group for Stomach Cancer-Second Study / K.Kato et al. / p446～446
• General Lecture 653. Adjuvant Chemotherapy with HCFU for Resectable Colorectal Carcinoma / T.Muto et al. / p446～446
• General Lecture 654. Prospective Adjuvant Chemotherapy of Mitomycin C plus HCFU for Colorectal Cancer (The Third Report) -7 Year Survival after Surgery / H.Ichihashi et al. / p447～447
• General Lecture 655. A Randomized Controlled Study on Adjuvant Chemotherapy with Mitomycin C and HCFU in Noncuratively Resected-Colorectal Cancer Patients(Fourth Report) / M.Niimoto et al. / p447～447
• General Lecture 656. Prospective Adjuvant Therapy of Carmofur(HCFU)plus PSK for Colorectal Cancer / T.Watanabe et al. / p447～447
• General Lecture 657. A Case of Hepatocellular Carcinoma(HCC) with Lung Metastasis which Responded to Chemotherapy with a Single Use of HCFU / Y.Kanda et al. / p448～448
• General Lecture 658. Combination Chemotherapy with Etoposide(E),Adriamycin(A),and Cisplatin(P)(EAP)for Advanced Gastric Cancer / A.Tanaka et al. / p448～448
• General Lecture 659. Effect of Concomitant Therapy of Cisplatin,MMC,UFT and Etoposide(PMU-E Therapy)on Terminal Stomach Cancer / T.Sawa et al. / p448～448
• General Lecture 660. Chemotherapy for Advanced and Recurrent Cancer Patients--Effects of Combination Chemotherapy Using Cisplatin,Peplomycin,Mitomycin C and Adriamycin / Y.Sato et al. / p449～449
• General Lecture 661. Phase II Study of Cisplatin for Gastric Carcinoma and Colon Carcinoma / K.Ishibiki et al. / p449～449
• General Lecture 662. Prognostic Factors in Unresectable Advanced Gastric Cancer Cases Treated by Chemotherapy / A.Ohtsu et al. / p449～449
• General Lecture 663. Experience of CDDP Therapy for Advanced or Recurrent Gastric Cancer--With Special References to the Relationship between Response Rate and Nuclear DNA Histogram / T.Chikaishi et al. / p450～450
• General Lecture 664. Preoperative Chemotherapy and Anti-cancer Effect of Stomach Carcinoma / K.Kumagai et al. / p450～450
• General Lecture 665. Prognosis of the Patients with Resectable Advanced Gastric Cancer, Treated by Preoperative Chemotherapy / S.Yoshida et al. / p450～450
• General Lecture 666. Preoperative Chemotherapy in Gastric and Colorectal Cancer / Y.Munemoto et al. / p451～451
• General Lecture 667. Preoperative Chemotherapy for Soft Tissue Sarcomas / Y.Aoki et al. / p451～451
• General Lecture 668. Advanced and Recurrent Gastric/Rectal Carcinoma Responding to Etoposide,Adriamycin and Cisplatin(EAP)Therapy / Y.Nakamura et al. / p451～451
• General Lecture 669. Clinical Evaluation of Combination Chemotherapy with Etoposide(Etop)/Adriamycin(ADM)/Cisplatin(CDDP)--EAP-in Advanced Gastrointestinal Cancer / T.Ohno et al. / p452～452
• General Lecture 670. Advanced and Recurrent Carcinoma of Digestive Organs:Combination Chemotherapy with Etoposide(E),Adriamycin(A), Cisplatin(P)=EAP / S.Owada et al. / p452～452
• General Lecture 671. Clinical Studies on Cisplatin-based Combination Cancerchemotherapy / N.Terata et al. / p452～452
• General Lecture 672. A Comparative Study of MMC+UFT and MMC+Tegafur Therapies for Advanced Cancer of Gastrointestinal Tract / Y.Inoue et al. / p453～453
• General Lecture 673. A Combination Chemotherapy with Adriamycin,Mitomycin C and Tegafur or 5-FU(AMF) for Advanced or Recurrent Cancer of Digestive Organ or Breast / Y.Rai et al. / p453～453
• General Lecture 674. Evaluation of Activity in Patients with Advanced Cancer during the Course of Chemotherapy with UFT,MMC,and Picibanil / S.Misawa et al. / p453～453
• General Lecture 675. The Combination Chemotherapy of MTX-5FU for Recurrent and Advanced Cancer Patients / T.Saeki et al. / p454～454
• General Lecture 676. Intravenous Infusion of 5-fluorouracil(1)Once-a-week Intermittent Administration / T.Nakatsu et al. / p454～454
• General Lecture 677. Trial Chemoendocrine Therapy(MAPET)for Stage D₂Prostatic Cancer / H.Kusuyama et al. / p454～454
• General Lecture 678. Combination Chemotherapy for Stage D₂, Advanced Prostatic Cancer with Ifosfamide,5-Fluorouracil,and Cisplatin / S.Takeuchi et al. / p455～455
• General Lecture 679. Phase II Study of Vindesine for Urogenital Cancer / J.Ochi et al. / p455～455
• General Lecture 680. Clinical Evaluation of PVB Chemotherapy for Testicular Cancer / N.Miyanaga et al. / p455～455
• General Lecture 681. Experience with a New Second Line Combination Chemotherapy for Testicular Tumors / H.Iizawa et al. / p456～456
• General Lecture 682. Clinical Research on Testicular Tumors--The Effectiveness of Chemotherapy in Relation to Resection of Metastatic Tumors / A.Furuhata et al. / p456～456
• General Lecture 683. CAF Chemotherapy on Advanced and Recurrent Breast Cancer(2nd Report) / C.Masuzawa et al. / p456～456
• General Lecture 684. Combined Chemotherapy with CDDP,VDS and VP-16 for CAF Therapy Resistant Relapsed Breast Cancer / O.Senga et al. / p457～457
• General Lecture 685. Postoperative Adjuvant Therapy for Breast Cancer / T.Morimoto et al. / p457～457
• General Lecture 686. Combination Chemotherapy Consisting of Mitomycin C,Methotrexate,5-FU(MMF)as Second Line for Refractory, Advanced Breast Cancer / T.Fujii et al. / p457～457
• General Lecture 687. Anti-tumor Effect of Trilostane(MWD-18)for Breast Cancer / K.Hayashi et al. / p458～458
• General Lecture 688. Not Received / /
• General Lecture 689. Combination Therapy with 5'-DFUR in the Treatment of Breast Cancer and Gastrointestinal Cancer / T.Taguchi et al. / p458～458
• General Lecture 690. Adjuvant Systemic Therapy for Resectable Breast Cancer]--Does Response Prolonged Survival? / H.Yamamoto et al. / p458～458
• General Lecture 691. Phase II Study of Combination Chemotherapy with Epirubicin(Epi),Cyclophosphamide(CPM)and Ftrafur(FT)for Metastatic Breast Cancer / M.Tabata et al. / p459～459
• General Lecture 692 Combination Chemo-endocrine Therapy of Metastatic Breast Cancer with Cyclophosphamide,Adriamycin,Prednisolone and Tamoxifen(CAPT) / Y.Nakamura et al. / p459～459
• General Lecture 693. Five-day Continuous Infusion of Vindesine and Vinblastine in the Treatment of Advanced Malignancies / N.Usui et al. / p459～459
• General Lecture 694. Evaluation of Quality of Life of Postmastectomy Patients by Questionnaire / T.Kiyoizumi et al. / p460～460
• General Lecture 695. Evaluation of the Quality of Life in Patients after Surgery for Gastric Cancer / S.Inaba et al. / p460～460
• General Lecture 696. Home Oxygen Therapy for the Lung Cancer Patient with Respiratory Insufficiency / Y.Noguchi et al. / p460～460
• General Lecture 697. The Investigation of Cure and Care in the Advanced Gastric Cancer / T.Fukuda et al. / p461～461
• General Lecture 698. The Role of Radiotherapy in the Hospice Care / T. Nishimura et al. / p461～461
• General Lecture 699. Clinical Evaluation of Morphine Sulfate Continous Tablet for the Patient of Gynecological Malignancy / S.Yokoyama et al. / p461～461
• General Lecture 700. The Study on the Effect of the Administration of Betamethasone to the Patient with Advanced Cancer at Terminal stage / M.Miyashita et al. / p462～462
• General Lecture 701. Opinion Research on Notification of Cancer and Terminal Care / K.Tsukada et al. / p462～462
• General Lecture 702. Lymphadenectomy for the Renal Pelvic and Ureteral Tumors / T.Okano et al. / p462～462
• General Lecture 703. Results of Treatment for Carcinoma of the Renal Pelvis and Ureter / M.Maruoka et al. / p463～463
• General Lecture 704. Clinical Assessment for Superficial Bladder Tumors Treated by Transurethral Resection(TUR) / H.Tsujihashi et al. / p463～463
• General Lecture 705. Treatment for T2 Transitional Cell Carcinoma of the Urinary Bladder / M.Kuroda et al. / p463～463
• General Lecture 706. Clinical Studies on Total Cystectomized Bladder Cancer at Nagasaki Central Hospital from 1982 to 1987 / M.Hayashi et al. / p464～464
• General Lecture 707. Surgical Treatment for Precancerous Lesions of the Colorectum / Y.Yamamoto et al. / p464～464
• General Lecture 708. Surgery for Small Rectal Carcinoid Tumors--Mainly 1 cm or Smaller Lesions / H.Tomoda et al. / p464～464
• General Lecture 709. Significance of Lateral Lymph Node Dissection in Rectal Cancer / M.Mori et at. / p465～465
• General Lecture 710. Anastomotic Recurrence after Sphincter-saving Resection for Rectal Cancer--A Possible Role of Free Malignant Cells in the Lumen / I.Fukuda et al. / p465～465
• General Lecture 711. Not Received / /
• General Lecture 712. Abdominal Surgery among Those over 90 Years of Age / T.Kunizaki et al. / p465～465
• General Lecture 713. Twenty-one Year Results of Treatment of Primary Operable Breast Cancer / T.Horino et al. / p466～466
• General Lecture 714. Significance of-Parastemal Dissection as Radical Mastectomy / M.Ogita et al. / p466～466
• General Lecture 715. Not Received / /
• General Lecture 716. Results of Full Thickness Chest Wall Resection in Patients with Chest Wall Recurrence of Breast Cancer / K.Miyauchi et al. / p466～466
• General Lecture 717. Clinical Evaluation of Modified Radical Mastectomy as Related to Locoregional Recurrence / G.Matsumiya et al. / p467～467
• General Lecture 718. Tumor Necrosis Effect by Endogenous Tumor Necrosis Factor(TNF)Induction Therapy / H.Shinohara et al. / p467～467
• General Lecture 719. Endogenous and Exogenous TNF Therapy on Metastatic or Local Recurrent Lesions of Colorectal Carcinoma / K.Takagi et al. / p467～467
• General Lecture 720. An Analysis of the Clinical Effect and the Cellular Immune Response with Endogenous TNF Induction Therapy for Colon Cancer with Liver Metastasis / M. Kusama et al. / p468～468
• General Lecture 721. Evaluation of the Effect of Natural Human TNF on Immune System / Y.Yasui et al. / p468～468
• General Lecture 722. Anti-tumor Effect of Human Recombinant Tumor Necrosis Factor(Hu-rTNF)and Clinical Evaluation / T.Otuki et al. / p468～468
• General Lecture 723. Endogenous Induction of Tumor Necrosis Factor Serum(TNS)for the Immunological Treatment of Cancer after Operation / Y.Abe et al. / p469～469
• General Lecture 724. Not Received / /
• General Lecture 725. Treatment of Recurrent Glioblastoma with PT-050,a Case Report / K. Kurisu et al. / p469～469
• General Lecture 726. TNF Activity in the Sera of Patients with Head and Neck Carcinoma / H.Suzuki et al. / p469～469
• General Lecture 727. Induction of Endogenous TNF Models by Streptococcal Preparation,OK-432 / M.Miyai et al. / p470～470
• General Lecture 728. Antitumor Therapy of Gynecological Malignancies in Advanced stages through Induction of Endogenous TNF / K.Dobashi et al. / p470～470
• General Lecture 729. A Case of Myosarcoma Uteri Treated with Endogenous Tumor Necrosis Factor(TNF) Induction Therapy / K,Taguchi et al. / p470～470
• General Lecture 730. Maintenance Immunochemotherapy for Hormonally-refractory Prostatic Cancer / T.Yamauchi et al. / p471～471
• General Lecture 731. A Histopathological Evaluation about Metastatic Lesions after EET Therapy / M.Kato et al. / p471～471
• General Lecture 732. Analysis of Conditions for LAK Cell Induction Using Synthetic Medium / T.Tsuchida et al. / p471～471
• General Lecture 733. Basic Investigation for Lymphokine Activated Killer Cell Induction / A.Murata et al. / p472～472
• General Lecture 734. Induction of LAK Cells by Long Term Culture / S.Takamoto et al. / p472～472
• General Lecture 735. Synergistic Effect of IL-2 and IFN-γ / T.Tsunoda et al. / p472～472
• General Lecture 736. Not Received / /
• General Lecture 737. The Effects of Neoplastic Drugs on Lymphokine Activate Killer(LAK)Activity and Natural Killer(NK)Activity / K.Yoshimori et al. / p473～473
• General Lecture 738. Examination of Lymphokine-Activated Killer(LAK)Activity in Patients with Esophageal Cancer / K.Shimoda et al. / p473～473
• General Lecture 739. Not Received / /
• General Lecture 740. A Case of Advanced Renal Cell Carcinoma Responded to the Combined Immunotherapy / A.Usui et al. / p473～473
• General Lecture 741. Clinical Trial of Tumor Ifiltrating Lymphocytes in Gynecological Cancer / G.Yahata et al. / p474～474
• General Lecture 742. Brain Metastases after Immunotherapy with Autologous Lymphokine-activated Killer Cells and Interleukin 2 in Patients with Metastatic Renal Cell Carcinoma / E.Nakano et al. / p474～474
• General Lecture 743. Induction of Autologous-tumor Specific Cytotoxic T Lymphocytes Restimulated in vitro with 1-butanol Extracted Tumor Antigen / K.Naito et al. / p474～474
• General Lecture 744. Adoptive Chemoimmunotherapy with Cyclophosphamide(CY),IL-2 and Lymphokine Acti-vated Killer(LAK)Cells / M.Takahashi et al. / p475～475
• General Lecture 745. LAK Cell Adoptive Immunotherapy in Combination with Plasma Exchange / T.Takayama et al. / p475～475
• General Lecture 746. Not Received / /
• General Lecture 747. Adoptive Immunotherapy of Malignant Diseases with Allogeneic LAK Cells / Y.Kimoto et al. / p475～475
• General Lecture 748. Long-term Effect of Intravesical Instillation of BCG to Prevent Recurrence in Patients with Bladder Tumor / S.Jitsukawa et al. / p476～476
• General Lecture 749. Prophylactic Effects of Intravesical Bacillus Calmette-Guerin on Superficial Bladder Tumor / K.Yoshikawa et al. / p476～476
• General Lecture 750. A Comparative Clinical Trial of Intravesical ECG and UFT Treatment in Superficial Bladder Cancer / H.Oda et al. / p476～476
• General Lecture 751. Subpopulations of Tissue Infiltrating Lymphocytes in Bladder Tumors Treated BCG Intravesical Instillution / T.Kawaguchi et al. / p477～477
• General Lecture 752. Preventive Effect of Human Urinary Trypsin Inhibitor on Postgastrectomy Immunosuppression in Gastric Cancer Patient / K.Ogoshi et al. / p477～477
• General Lecture 753. A Statistical Analysis on Cancer Patients in Treatment with S.S.M. (An Extract from Human Tubercle Bacilli
• Maruyama Vaccine) -Report X / K.Fujita et al. / p477～477
• General Lecture 754. Clinical Experiences of Plasma Perfusion over Immobilized Protein A(Pro-TAK)in Cancer Patients / T.Okada et al. / p478～478
• General Lecture 755. Studies on Removal Effect of Immunosuppressive Factor by Protein A Column With Special References to the Augmentation on Cell Mediated Immunity of PBL and LAK Cells / T.Ooiwa et al. / p478～478
• General Lecture 756. Clinical Studies on Plasma Perfusion over Immobilized Protein A in the Treatment of Cancer / S.Hata et al. / p478～478
• General Lecture 757. Case Reports on Terminal Cancer of Urogenital Organs with Remarkable Efficacy Attained by Immuno-surveillance Therapy / I.Sato et al. / p479～479
• General Lecture 758. Effects on Malignant Tumors of Treatment Combinding Radiotherapy with TCA Therapy / Y.Suzuki et al. / p479～479
• General Lecture 759. Toxicity of M-VAC Therapy in Rats / H.Matsuki et al. / p479～479
• General Lecture 760. Histopathological Study Regarding the Protective Effect of Elastase on Cisplatin-induced Renal Toxicity / M.Ohwada et al. / p480～480
• General Lecture 761. Effect of Cisplatin on Mouse Spermatozoa / S.Oshio et al. / p480～480
• General Lecture 762. Comparative Evaluation of Murine Oocyte Toxicity Following Intraovarian Injection and Intraperitoneal Infusion with Oncostatics / I.Yokoo et al. / p480～480
• General Lecture 763. Effective Dose of 50% Destruction for Murine Oocyte Following Intraperitoneal Infusion of 12 Oncostatics / K.Takizawa et al. / p481～481
• General Lecture 764. Characterization of Cisplatin Resistant Human Lung Cancer Cell Lines / Y.Fujiwara et al. / p481～481
• General Lecture 765. Mechanisms of Resistance to Cisplatin in Ovarian Carcinoma Cells / T.Oosaki et al. / p481～481
• General Lecture 766. Establishment of the Drug resistant Ovarian Cancer Cell Lines and Their Characterization / K.Mizuno et al. / p482～482
• General Lecture 767. The Effect of Diprydamole on Cytotoxicity of Cisplatin Analogs in Parent and Cisplatin Resistant Ovarian Cell Lines / M. Hatae et al. / p482～482
• General Lecture 768. Not Received / /
• General Lecture 769. The Effect of Verapamil,Cyclosporin A or Buthionine-S,R-sulfoximine to Overcome the Drug Resistance against Primary Culture Cells / K.Minato et al. / p482～482
• General Lecture 770. Not Received / /
• General Lecture 771. A Case of Advanced Uterine Corpus Carcinoma Successfully Treated by Intra-arterial Chemotherapy Followed by Radical Operation / Y.Satow et al. / p483～483
• General Lecture 772. Repertitive Intra-arterial Chemotherapy for Recurrence of Carcinoma of the Uterine Cervix / H Tanaka et al. / p483～483
• General Lecture 773. A Trial for Individualization of Intra-arterial Infusion Chemotherapy / K.Fujiwara et al. / p483～483
• General Lecture 774. Consecutive Intraarterial Infusion in Patients with Cervical Cancer Recurrent in the Pelvis after Radiation / S.Shiokawa et al. / p484～484
• General Lecture 775. Clinical and Pathological Study in Preoperative CDDP Intra-arterial Chemotherapy for Cervical Cancer / T.Kondoh et al. / p484～484
• General Lecture 776. Long Term Management of the Intra-arterial Catheter in the Internal Iliac Arteries / K.Kawagoe et al. / p484～484
• General Lecture 777. Pharmacokinetics of CDDP Administered as a Short-term Intra-arterial Infusion(Second Report) / T.Kurose et al. / p485～485
• General Lecture 778. Mesenterio-intra-arterial Infusion Chemotherapy for Peritonitis Carcinomatosa in Ovarian Cancer Patients / S.Adachi et al. / p485～485
• General Lecture 779. Intra-arterial Chemotherapy of Advanced Gynecological Carcinoma Using Totally Implantable Delivery System / H.Inoue et al. / p485～485
• General Lecture 780. Transcatheter Arterial Embolization in Cases of Recurrent and Advanced Cervical Cancer / Y.Harima et al. / p486～486
• General Lecture 781. Application of Lymphadenectomy and Intraoperative Radiation Therapy of the Paraaortic Lymph Nodes in Advanced Cervical Cancer / T.Miyamoto et al. / p486～486
• General Lecture 782. Intraoperative Radiotherapy for Recurrent Uterine Cancer / J.Oomagari et al. / p486～486
• General Lecture 784. Experience of Step Wedges Used to Shield the Midline during External Irradiation for Carcinoma of Uterine Cervix / H.Sekine et al. / p487～487
• General Lecture 785. Preoperative Irradiation Therapy for Vulva Carcinoma / H.Gomi et al. / p487～487
• General Lecture 786. Intravesical or Intrarectal Instillation of Maalox for the Treatment of Radiation Cystitis or Proctitis / Y.Koizumi et al. / p487～487
• General Lecture 787. High-Dose Rate Intracavitary Therapy for Carcinoma of the Uterine Cervix:Prospective Randomized Study of Point A Dose of 7.5 Gy vs 6 Gy/Fraction / T.Teshima et al. / p488～488
• General Lecture 788. High Dose Rate Intracavitary Radiotherapy of Recurrent Cervical Cancer / H.Kumagai et al. / p488～488
• General Lecture 789. The Prognosis of Cervical Cancer Patients in Reference to Its Radio-sensitivity / T.Hamada et al. / p488～488
• General Lecture 790. Experimental Studies on Irradiation Effect with Anticancer Drugs / K.Morishita et al. / p489～489
• General Lecture 791. Relationship between Prognosis and Lymph Node Metastases with Postoperative Radiother-apy of Carcinoma of the Uterine Cervix / M.Kumano et al. / p489～489
• General Lecture 792. Correlation between the Prognosis and Cytology and Histology during Irradiation for Cervical Cancer / M.Takahashi et al. / p489～489
• General Lecture 793. Remote Afterloading Transurethral Radiotherapy for Prostatic Cancer / T.Kigure et al. / p490～490
• General Lecture 794. Study on Conformation Radiotherapy for Prostatic Carcinoma / T.Takahashi et al. / p490～490
• General Lecture 795. Clinical Evaluation of Intracavitary Radiotherapy for Bladder Cancer / T.Inoue et al. / p490～490
• General Lecture 796. Combined Cisplatin and Radiation Therapy for Advanced Bladder Cancer / M.Matsushima et al. / p491～491
• General Lecture 797. Conbination Effects of Proton and CDDP on the Invasive Bladder Carcinoma in Mice / M.Ohtani et al. / p491～491
• General Lecture 798. Radiation Therapy for Nasopharyngeal Carcinoma / H.Uozumi et al. / p491～491
• General Lecture 799. Radiotherapy of Oropharyngeal Squamous Cell Carcinoma / M.Uematsu et al. / p492～492
• General Lecture 800. Results of Radiotherapy for T1N0M0 Glottic Carcinoma / T.Inoue et al. / p492～492
• General Lecture 801. Results of Radiotherapy for T1.2 Supraglottic Carcinoma / Y.Matayoshi et al. / p492～492
• General Lecture 802. Long-term Results in T1 Glottic Carcinoma / M.Saikawa et al. / p493～493
• General Lecture 803. Preoperative Radiotherapy for Invasive Thymoma / K.Ohara et al. / p493～493
• General Lecture 804. Prognostic Factor of Patients with stage I,II ca.of the Tongue Treated by Interstitial Radiotherapy / K.Jingu et al. / p493～493
• General Lecture 805. Malignant Tumors Metastatic to the Mouth / T.Shimizu et al. / p494～494
• General Lecture 806. Results of Radiotherapy for Maxillary Sinus Cancer / K.Matsuki et al. / p494～494
• General Lecture 807. Treatment of MO-advanced Head and Neck Cancer by Combined Radiotherapy with Misonidazole and Vidarabine / H.Asakura et al. / p494～494
• General Lecture 808. Radiosensitivity Test for Carcinomas through Immunohistochemical Method / A.Nishioka et al. / p495～495
• General Lecture 809. Modified Arc Therapy for TSEI,TBI and Large Field Irradiations--A Susequent Report / M.Daimon et al. / p495～495
• General Lecture 810. Contrast Enhancement and Treatment Policies in Grade II Gliomas / A.Akanuma et al. / p495～495
• General Lecture 811. Intraoperative Radiation Therapy(IORT)for Cerebral Glioblastoma / M.Matsutani et al. / p496～496
• General Lecture 812. Radiotherapy of Central Neurocytoma / K.Nakagawa et al. / p496～496
• General Lecture 813. Not Received / /
• General Lecture 814. Proton Therapy for Ocular Malignancy / S.Morita et al. / p496～496
• General Lecture 815. A Preliminary Report of Endocrine Chemotherapy in Endometrial Cancer / Y.Katsube et al. / p497～497
• General Lecture 816. Inhibition of Metastasis in Gynecologic Malignant Tumors by Medroxyprogesterone Acetate with Reference to Tumor Angiogenesis Factor and Fibroblast Growth Factor / S.Hosoda et al. / p497～497
• General Lecture 817. Steroid Hormone Producing Activity of Ovarian Endometrioid Adenocarcinoma / Y.Ino et al. / p497～497
• General Lecture 818. Clinical Evaluation of Medroxyprogesterone Acetate and 5-Fluorouracil for Maintenance Therapy of Prostatic Carcinoma / K. Kojima et al. / p498～498
• General Lecture 819. Treatment of stage D₂ Prostate Cancer Patients with Hormones in Combination with Cyclophosphamide / I.Nakamura et al. / p498～498
• General Lecture 820. Therapeutic Effects on Carcinoma Cells in Prostatic Fluid / S.Ichijo et al. / p498～498
• General Lecture 821. A Combination Therapy with MPA and 5'DFUR as a Second Line Treatment for Advanced/Recurrent Breast Cancer(Second Report) / H. Koyama et al. / p499～499
• General Lecture 822. Not Received / /
• General Lecture 823. Time-course of Estrogen and Progesterone Receptor Contents during Tamoxifen-medroxyprogesterone Sequential Therapy for Breast Cancer / S.Noguchi et al. / p499～499
• General Lecture 824. A Comparison of Two Doses of Tamoxifen in the Patients with Advanced Breast Cancer:40 mg/day v.s. 20 mg/day / Y.Takatsuka et al. / p499～499
• General Lecture 825. Clinical Trial of Combination Therapy with Medroxyprogesterone Acetate plus Tegafur for Adriamycin and Tamoxifen Resistant Advanced Breast Cancers / T.Wada et al. / p500～500
• General Lecture 826. Adjuvant Chemo-endocrine Therapy with Tegafur and Tamoxifen for Breast Cancer(1st.Report) / H.Koyama et al. / p500～500
• General Lecture 827. The Effects of the Combined Use of Testosterone and Tamoxifen on DMBA-induced Mammary Tumor in Rats / N.Okuyama et al. / p500～500
• General Lecture 828. Dose-related Side Effects and Plasma Concentration of MPA / M.Fukuda et al. / p501～501
• General Lecture 829. Changes of Estrogen Receptor Expression by Endocrine Therapy in Breast Cancer / M.Toi et al. / p501～501
• General Lecture 830. Prognostic Value of Estrogen and Progesterone Receptor Determinations in Patients with Primary Operable Breast Cancer / J.Kurebayashi et al. / p501～501
• General Lecture 831. Comparison of Modified Charcoal-gelatin(MCG)Method with Standard DCC for Estrogen Receptor Assay / S.Masamura et al. / p502～502
• General Lecture 832. Study of the Hormone Dependency of Human Breast Cancer by Using Serum-free Culture / K.Urazumi et al. / p502～502
• General Lecture 833. A Study on Aromatase and Sulfatase Activities in Breast Cancer Tissue / T.Utsumi et al. / p502～502
• General Lecture 834. Antitumor Effects and Endcrine Status of New Aromatase Inhibitor(CGS 19649 A)on DMBA-Induced Rat Mammary Cancer / T.Hohjoh et al. / p503～503
• General Lecture 835. Estrogen Receptor in Gastric Cancer and Early Results of Endocrine Treatment for Gastric Cancer / A.Tokunaga et al. / p503～503
• General Lecture 836. Effect of Tamoxifen to Human Gastric Cancer Cell Lines:A Flow Cytometry Analysis / H.Ohkura et al. / p503～503
• General Lecture 837. Estrogen Receptor Related Antigen(ER-D5)in Gastric Cancer / H.Matsumoto et al. / p504～504
• General Lecture 838. Immunohistochemical Study of Estradiol,Cholesterol Side-chain Cleavage Enzyme,Aromatase,Estrogen Receptor in Gastric Cancer / Y.Saitou et al. / p504～504
• General Lecture 839. Prognosis of Breast Cancer Patients and ER Stainability / M.Matsui et al. / p504～504
• General Lecture 840. Not Received / /
• General Lecture 841. On the Correlation of Immunocytochemically Demonstrated Estrogen Receptor Status(ER-ICA)and Histopathological Features in Breast Cancer / H.Matsukawa et al. / p505～505
• General Lecture 842. Studies on Susceptibility to Chemotherapeutic Agents and Targeting Chemotherapy Using Multicellular Tumor Spheroid(MTS) / S.Inoue et al. / p505～505
• General Lecture 843. Targeting Chemotherapy by Transferrin-neocarzinostatin Conjugate:Relationship between the Molar Ratio of NCS and the Antitumor Effect / J.Kato et al. / p505～505
• General Lecture 844. An Experimental Study on Antitumor Effect of Prostaglandin D₂ / H. Ehara et al. / p506～506
• General Lecture 845. Effects of δ 12-prostaglandin J₂ on Tumor Proliferation / G.Nishimura et al. / p506～506
• General Lecture 846. Indomethacin Enhances the Cytostatic Effect of CDDP on the Cell Growth of the Uterine Cervical Cancer in Cell Line / M.Ogino et al. / p506～506
• General Lecture 847. Inhibitory Effect of Antitumor Drugs-induced Sister Chromatid Exchanges by Im-munopotentiator PS-K / J.Hasegawa et al. / p507～507
• General Lecture 848. Dipyridamole Enhances Cytotoxic Effect of Adriamycin on the Tumor Cells / K.Hidaka et al. / p507～507
• General Lecture 849. Effects of α-Difluoromethylornithine,Methylglxal-bis-guanylhydozone and Recombinant Interferon-γ on the Growth of Human Breast Cancer(R-27)in Nude Mice / T.Koga et al. / p507～507
• General Lecture 850. Experimental Lung Cancer Chemotherapy Using Transplantable Human Lung Cancer in Nude Mice / M.Imaizumi et al. / p508～508
• General Lecture 851. Antitumor Effect of 5FU by Administration Schedule on Human Gastric Cancer Transplanted in Nude Mice / D.Saito et al. / p508～508
• General Lecture 852. Antitumor Activity of Mitomycin C Analogous Compounds(KT 6149 and RM-49)against Human Tumor Xenografts Serially Transplanted into Nude Mice / T.Kubota et al. / p508～508
• General Lecture 853. Not Received / /
• General Lecture 854. Transport and Intracellular Metabolism of Fluoropyrimidines in Intraperitoneally Cultured and in-vitro Cultured HeLa-S₃Cells / M.Uchida et al. / p509～509
• General Lecture 855. Preoperative Intra-arterial Infusion Chemotherapy for Patients with T2/T3 Bladder Cancer / Y.Kubota et al. / p509～509
• General Lecture 856. Multidisciplinary Treatment Including Intraarterial Infusion Chemotherapy for Advanced Bladder Cancer / T.Tochigi et al. / p509～509
• General Lecture 857. Radiation and Intra-arterial Chemotherapy with Angiotensin II to Bladder Cancer / T.Nasu et al. / p510～510
• General Lecture 858. Efficacy of Intraarterial Chemotherapy Using CDDP on Rat Bladder Tumors Induced by BBN / Y.Furukawa et al. / p510～510
• General Lecture 859. Immunological Effects of Recombinant Interferon-γ Infused by Renal Artery for Renal Malignancies / S.Isaka et al. / p510～510
• General Lecture 860. Tumor-targeted Chemotherapy with Lipid Contrast Medium and Macromolecular Anti-cancer Drug(SMANCS)for Renal Cell Carcinomas Renal Arterial Administration of SMANCS/Lipiodol Hyper Viscosity / M.Kobayashi et al. / p511～511
• General Lecture 861. Transcatheter Arterial Oily Chemoembolization of Renal Carcinoma with Adriamycin-Lipiodol-emulsion / T.Nishiyama et al. / p511～511
• General Lecture 862. Countrermeasures to Cope with Problems Relating to Continuous Intraarterial Infusion Therapy / Y.Nomura et al. / p511～511
• General Lecture 863. A Study of Long Term Results of Intra-arterial Chemotherapy of Breast Cancer, Especially in Local Control / S.Takehara et al. / p512～512
• General Lecture 864. Intra-arterial Infusion Chemotherapy on Primary Advanced Breast Cancer--Effect and Side Effect of ADR and. 4'-epi-ADR / K.Toda et al. / p512～512
• General Lecture 865. Intra-Arterial Chemotherapy with CDDP for Primary Mediastinal Seminoma / H. Kuritsuka et al. / p512～512
• General Lecture 866. Preoperative Chemotherapy of Osteosarcoma with Intra-arterial Cisplatin / A. Suda / p513～513
• General Lecture 867. The Use of IAP in the Judgement of Therapeutic Effects in the Treatment of Patients with Ranal Cell Carcinoma / M.Hoshino et al. / p513～513
• General Lecture 868. Significance of Serum IAP,TPA and Ferritin Levels in Renal Cell Carcinoma / T. Igarashi et al. / p513～513
• General Lecture 869. Clinical Evaluation of Basic Fetoprotein(BFP)in Human Renal Cell Carcinoma / K. Gohji et al. / p514～514
• General Lecture 870. Clinical Evaluation of Serum BFP Levels in Urogenital Tumors and Urinary BFP Levels in Bladder Cancer / Y.Nagatani et al. / p514～514
• General Lecture 871. Usefulness of Urinary BFP(Basic Fetoprotein)as a Marker for Detecting Urothelial Malignancies / T.Tsujii et al. / p514～514
• General Lecture 872. Clinical Studies on the Measurement of Urinary TPA Levels in Urothelial Cancer / T.Ohashi et al. / p515～515
• General Lecture 873. Screening Examination for Bladder Cancer
• Measurement of Antigens in Urine by Using Monoclonal Antibodies / Y.Aga et al. / p515～515
• General Lecture 874. Clinical Significance of PAP in stage D₂ Prostatic Carcinoma / Y.Satoh et al. / p515～515
• General Lecture 875. Role of γ-Seminoprotein(γ-Sm)and Prostatic Acid Phosphatase(PAP)as the Tumor Markers of Prostatic Cancer / M.Watanabe et al. / p516～516
• General Lecture 876. Clinical Evaluation of Serum Prostatic Specific Antigen, γ-seminoprotein and Prostatic Acid Phosphatase in Prostatic Cancer / Y. Arai et al. / p516～516
• General Lecture 877. The Usefulness of PAP, γ-Sm and PA as the Evaluation of Clinical Effects in the Treatment of Prostatic Cancer / K.Ohta et al. / p516～516
• General Lecture 878. Comparative Evaluation Study of PAP, PA and γ-Sm as Tumor Markers for Prostatic Cancer Patients / H. Ito et al. / p517～517
• General Lecture 879. Indication of Adjuvant Hepatic Arterial Chemotherapy after Hepatectomy for Hepatoma According to Analysis of Risk Jaetors of Recurrence / T. Nonami et al. / p517～517
• General Lecture 880. Not Received / /
• General Lecture 881. Evaluation of Cancer Chemotherapy Using Implantable Reservoirs / Y. Tsuji et al. / p517～517
• General Lecture 882. Not Received / /
• General Lecture 883. Therapeutic Effect on Small Hepatocellular Carcinoma / K.Sakamoto et al. / p518～518
• General Lecture 884. Targeting Chemotherapy for Hepatoblastoma in Childhood by Arterial Administration of Anticancer Agents Dissolved in Lipiodol / N.Ohnuma et al. / p518～518
• General Lecture 885. Chemo-embolization Therapy for the Unresectable Liver Cancer in Childhood / F.Sasaki et al. / p518～518
• General Lecture 886. Not Received / /
• General Lecture 887. Not Received / /
• General Lecture 888. Clinical Evaluation of TAI and TAE Therapy for Liver Metastasis / A. Matsuba et al. / p519～519
• General Lecture 889. Clinical Analysis of 10 Cases of Hepatocellulare Carcinoma Survived over 3 Years with Treatment of Transcatheter Arterial Embolization / S.Isomura et al. / p519～519
• General Lecture 890. Clinical Usefulness of TAE for Postoperative Recurrent Hepatoma / E.Kyoh et al. / p519～519
• General Lecture 891. The Role of Antineoplastic Solution in Transcatheter Hepatic Arterial Embolization -Second Report- / M.Tsuda et al. / p520～520
• General Lecture 892. Not Received / /
• General Lecture 893. Clinical Evaluation of SSEA-1 Antigen in Patients with Lung Cancer / S. Ikeda et al. / p520～520
• General Lecture 894. Clinical Evaluation of Siaryl SSEA-1 Antigen for Lung Disease / K. Takaoka et al. / p520～520
• General Lecture 895. Serum TPA(IRMA)Levels in Lung Cancer Patients / O. Nishimura et al. / p521～521
• General Lecture 896. Study of Primary Lung Cancers Associated with High Serum CEA / M.Suyama et al. / p521～521
• General Lecture 897. Clinical Evaluation of a New Tumor Marker, CA 130, in Patients with Lung Cancer / Y.Matsubara et al. / p521～521
• General Lecture 898. Clinical Studies on a New Tumor-associated Antigen, ATM-1 in Lung Cancer and Mediastinal Malignant Disease / Y.Kajiyama et al. / p522～522
• General Lecture 899. Clinical Evaluation of the Possibility of Tumor Marker Monitoring for Breast Cancer Patients Using CEA and CA 15-3 / M.Yoshimoto et al. / p522～522
• General Lecture 900. Efficacy of Treatment for Recurrent Breast Cancer and Changes in Serum CEA / H.Imamura et al. / p522～522
• General Lecture 901. Investigation of Tumor Markers in Cases of Progressive Recurrent Breast Cancer / K. Katayama et al. / p523～523
• General Lecture 902. Clinical Evaluation of ATM-1 as a New Tumor Marker of Breast Cancer / M.Koike et al. / p523～523
• General Lecture 903. Measurement of Tumor Markers in Nipple Discharge / H.Sato et al. / p523～523
• General Lecture 904. Immunohistochemical Study of the Monoclonal Antibody DF3 in Breast Cancer / M.Nihei et al. / p524～524
• General Lecture 905. Prognostic Usefulness of Helix Pomatia and Carcinoembryonic Antigen Histochemistry in Breast Carcinomas / T.Fukutonu et al. / p524～524
• General Lecture 906. Hepatic Arterial Infusion Chemotherapy with Cisplatin Suspension in Lipiodol(LPS)for Hepatocellular Carcinoma / J.Shibata et al. / p524～524
• General Lecture 907. Intraarterial Injection Therapy of CDDP-phosphatidyl Choline-lipiodol Suspension(CPLS)for Hepatoma / I.Isomoto et al. / p525～525
• General Lecture 908. Histological Studies on CDDP-LPD Therapy for Hepatocellular Carcinoma / T.Nakanishi et al. / p525～525
• General Lecture 909. Effect of Intra-arterially Injected Cis-platinum and Lipiodol on Rat Liver / A.Kawakami et al. / p525～525
• General Lecture 910. Aclalubicin/Lipiodol Solution (ACR/LPD) with Meylon as a Material for Oil-Chemo-Embolization
• Fundamental Study / Y.Terashima et al. / p526～526
• General Lecture 911. Experimentary Evaluation of Lipiodol Chemoembolization with a New Oil Soluble Anticancer Agent KM 2210:Estradiol-chlorambucil / H.Egawa et al. / p526～526
• General Lecture 912. Effects of TAE Following Lp Infusion into Hepatic Artery on Normal Liver in Dog / K.Kishi et al. / p526～526
• General Lecture 913. The Experimental Study for the 5FU-MTX Sequential Chemotherapy to Metastatic Liver Tumor Using Continuous Infusion / T.Mori et al. / p527～527
• General Lecture 914. Pharmacokinetic Analysis of ADM by Intra-arterial Chemotherapeutic Injection in Rabbit Models / H.Iwasaki et al. / p527～527
• General Lecture 915. Not Received / /
• General Lecture 916. Trial Manufacture and Use of CDDP Coarse Crystals as a Material for Chemoembolization -1st Report- / T.Komatsu et al. / p527～527
• General Lecture 917. Comparison of the Effects of Intra-arterial(IA)and Intra-venous(IV)Cisplatin on Both Limb Tumor and Lung Metastases of Rats / Y.Iwamoto et al. / p528～528
• General Lecture 918. Clinical Implications of Blood Carcinoembryonic Antigen in Stomach Cancer Patients / M.Furusawa et al. / p528～528
• General Lecture 919. The Usefulness of CEA Determination in Gastric Cancer / H.Kuniyasu et al. / p528～528
• General Lecture 920. Clinical Significance of Tumor Markers in Gastric Cancer / Y.Ashida et al. / p529～529
• General Lecture 921. Clinical Evaluation of Serum Level of Carbohydrate Antigen SPan-1 in Primary Gastric Cancer / T.Kubo et al. / p529～529
• General Lecture 922. Serum ATM1 in the Patients of Gastric Carcinoma / M. Hiraishi et al. / p529～529
• General Lecture 923. Diagnosis of the Recurrence of Gastric Cancer after Total Gastrectomy by Urinary Pep-sinogen I / T.Yamaguchi et al. / p530～530
• General Lecture 924. Clinical Assessment of the Tumor Marker,NCC-ST439,for Colorectal Cancer / Y.Kurosaka et al. / p530～530
• General Lecture 925. Evaluation of a New Tumor Marker of Colon Cancer / Y. Chimori et al. / p530～530
• General Lecture 926. Analysis of Tumor Markers on Post Operative Status in the Patient with Recurrence of Colorectal Cancer / N. Kojima et al. / p531～531
• General Lecture 927. Not Received / /
• General Lecture 928. Not Received / /
• General Lecture 929. Serum and Tissue Vitamin A Levels (S-VA and T-VA) in Gastric and Colo-rectal Cancer Patients / S.Nakamura et al. / p531～531
• General Lecture 930. Transcatheter Chemoembolization with Mitomycin C Microcapsules Combined with Lipiodol in the Treatment of Liver Cancer / T.Kato et al. / p531～531
• General Lecture 931. Not Received / /
• General Lecture 932. Clinical Trial of Selective Intra-arterial Chemotherapy Utilizing Microencapsulated Anticancer Drugs / K. Sato et al. / p532～532
• General Lecture 933. Not Received / /
• General Lecture 934. Fundamental and Clinical Studies on Prophylaxis of Hepatic Metastasis of Colorectal Cancer by Continuous Intraportal Infusion / K. Yaegashi et al. / p532～532
• General Lecture 935. The Long Term Arterial Infusion Chemotherapy to the Patient of Metastasis and Recurrence / T.Suga et al. / p532～532
• General Lecture 936. Two Cases of Intraperitoneal Recurrent Liposarcoma Treated by Continuous Intra-arterial Infusion Chemotherapy / T. Ohta et al. / p533～533
• General Lecture 937. Adjuvant Therapy against Gastric Cancer with Liver Metastasis / H.Kikuchi et al. / p533～533
• General Lecture 938. Conteneous Intraarterial Iufusion Therapy for Liver Metastasis of Large Bowel Cancer / K. Sasaki et al. / p533～533
• General Lecture 939. Hepatic Arterial Infusion Chemotherapy of FAM in the Patients with Non-resectable Liver Metastases(The 4th Report) / Y.Arai et al. / p534～534
• General Lecture 940. Effect of PMU Chemotherapy (Intra-arterial) for Liver Metastases of Gastric Cancer(Second Report) / N. Matsuki et al. / p534～534
• General Lecture 941. The Low Dose-intermittent Intraarterial Infusion Chemotherapy with Implanted Silicon Reservoir to Metastatic Liver Cancer / T. Kakuta et al. / p534～534
• General Lecture 942. Intraarterial Chemotherapy Combined with Degradable Starch Microspheres(DSM)for Liver Metastasis of Gastric Cancer and Colorectal Cancer / H.Takano et al. / p535～535
• General Lecture 943. The Clinical Usefulness of Serum Sialyl SSEA-1 Levels in Patients with Ovarian Cancer / H. Kobayashi et al. / p535～535
• General Lecture 944. Clinical Usefulness of Serum Sialyl SSEA-1 Antigen(SLX)in Gynecological Area / Y.Date et al. / p535～535
• General Lecture 945. Studies on Clinical Significance of Serum Type III Procoliagen Peptide as Tumor Marker in Patients with Ovarian Tumors / T.Mori et al. / p536～536
• General Lecture 946. Studies on the Usefulness of Tumor Marker MKS-15 (CA 54/61) in the Field of Obstetrics and Gynecology / Y.Yoshizawa et al. / p536～536
• General Lecture 947. Detection of Serum Antibody(OVC Ab)to Cell Surface Antigen Specific for Ovarian Cancer / Y.Ogino et al. / p536～536
• General Lecture 948. Dissociation of Tumor Markers during Chemotherapy in Ovarian Cancers / E. Kuki et al. / p537～537
• General Lecture 949. Alteration of Tumor Markers during the Course of Chemotherapy for Ovarian Cancer / A.Tsujii et al. / p537～537
• General Lecture 950. Studies of Serum Tumor Markers of Patients with Recurrent Ovarian Cancer / S. Morikawa et al. / p537～537
• General Lecture 951. Clinical Significance of Discriminant Analysis (DA) Employing Three Tumor Markers [CA 125. α₁ antitrypsin (α₁ AT), TPA] for Patients (pts) with Adnexal Mass / M. Kawai et al. / p538～538
• General Lecture 952. Application of Computer Automatic Multivariate and Pattern Analysis System (CAMPAS) to Ovarian Carcinoma in stage I--Comparing with Image Diagnosis / S. Kobayashi et al. / p538～538
• General Lecture 953. Clinical Use of Tumor Markers in Patients with Endometrial Carcinoma / Y.Negishi et al. / p538～538
• General Lecture 954. Placental Protein 19 in Choriocarcinoma Patient / H.Funayama et al. / p539～539
• General Lecture 955. Pharmacokinetic Study of Adriamycin in Peripheral Blood under Intraarterial Injection / H.Iwase et al. / p539～539
• General Lecture 956. Not Received / /
• General Lecture 957. Phase 1 Study of Etoposide for Primary Liver Neoplasms by a Single Arterial Infusion / H.Yasuda et al. / p539～539
• General Lecture 958. Experimental Study on Hypertensive Intraarterial Chemotherapy with Angiotensin- II--Analysis of 5-FU Concentrations Intissues of Gastric Cancer / N.Takahashi et al. / p540～540
• General Lecture 959. Not Received / / p540～540
• General Lecture 960. A Pharmacokinetic Study of Etoposide in Patients with Lung Cancer / R.Honda et al. / p540～540
• General Lecture 961. Not Received / /
• General Lecture 962. Second Line Chemotherapy for Ovarian Cancer -Report II, Parmacokinetics of BEC(BH-AC+Etoposide+CDDP)Therapy- / T.Noda et al. / p540～540
• General Lecture 963. Pharmacokinetics of MTX and Toxities of Sequential MTX and 5-FU (MXF) Treatment / A.Nashimoto et al. / p541～541
• General Lecture 964. Bolus and Maintenance Infusion of High-dose Methoterxate / K.Amino et al. / p541～541
• General Lecture 965. Intravesical Chemotherapy Using an Adhensive Preparation of Peplomycin in the Treatment of Patients with Bladder Cancer / S.Tanaka et al. / p541～541
• General Lecture 966. The Predictive Value of Serum CA-125 Levels at Second Look Operation (SLO) for Ovarian Cancer / T.Miyoshi et al. / p542～542
• General Lecture 967. The Relation between Chronology and Tumor Marker CA 125 in Ovarian Cancer / H.Wada et al. / p542～542
• General Lecture 968. Immunohistochemical and Ultrastructural Analysis of 4 Cases of Ovarian Immature Teratoma / S.Natsuyama et al. / p542～542
• General Lecture 969. Ultrastructural Localization of CA 19-9 in Ovarian Cancer / M.Matsuta et al. / p543～543
• General Lecture 970. Tumor-associated Antigen CA130 in Gynecologic Tumors:Its Immunohistochemical Distribution and Serum Levels / H.Nonogaki et al. / p543～543
• General Lecture 971. Immunohistochemical Reactivity of CAl25,CA15-3(115D8,DF3),CA19-9,CEA,9A3,SCC,TPA,EMA and PLAP in Common Epithelial Tumors of the Ovary / K.Shigemasa et al. / p543～543
• General Lecture 972. A Study about Release Mechanism of CA 125 from Tumor Tissue to Circulation / Y.Kiyozuka et al. / p544～544
• General Lecture 973. Determination of Total Renin Concentration in Plasma of Children with Malignant Solid Tumors / Y.Mochida et al. / p544～544
• General Lecture 974. New Prognostic Classification of Neuroblastoma from Disease stage,Age and N-myc Amplification / A.Nakagawara et al. / p544～544
• General Lecture 975. Clinical Evaluation of IAP for Bone and Soft Tissue Tumor / J.Manabe et al. / p545～545
• General Lecture 976. Thyroid Function in Cancer Bearing Rabits / Y.Hashimoto et al. / p545～545
• General Lecture 977. Clinical Application of Cappilary Zone Electrophoresis for Polyamine Analysis / A.Hori et al. / p545～545
• General Lecture 978. Influence of a Carcinogenic Substance, ENNG, and an Immunoactivator,RBS(Rice Bran Saccharide),on the Rat Polyamine Fraction Value / I Takeyoshi et al. / p546～546
• General Lecture 979. A Study of the Pharmacodynamics Following Oral Dosages of Pyrimidine Fluorides in Breast Cancer / A.Kosaka et al. / p546～546
• General Lecture 980. A Study of Pre-operative Chemotherapy in Colorectal Carcinoma / H.Sawa et al. / p546～546
• General Lecture 981. 5-FU Concentration in Tissue of Colorectal Cancer after Intrarectal Administration of FT-207 / K.Ishimoto et al. / p547～547
• General Lecture 982. 5-FU Concentration in Serum and Tissue of the Patients with Renal Cell Carcinoma after Oral Administration of UFT / S.Ozono et a1. / p547～547
• General Lecture 983. Study on the Concentration of Uracil in Normal and Tumor Tissue with or without UFT Administration(2nd Report) / T.Komita et al. / p547～547
• General Lecture 984. Not Received / /
• General Lecture 985. The Long-term Effect on Serum 5-FU Concentration of Administration of UFT / Y.Yamamoto et al. / p548～548
• General Lecture 986. Fraction of HCFU and Concentration of 5-FU in the Blood of Postoperative Patient with Digestive Tract Cancer after Oral Administration of HCFU / Y.Kuroda et al. / p548～548
• General Lecture 987. Clinical Evaluation of Anti-tumor Effects and Side Effect on the Combined Use of 5FU and L-cysteine in the Treatment of Gastric Cancer / I.Mizuno et al. / p548～548
• General Lecture 988. 5-Fu and Uracil Concentration and Thymidylate Synthase Inhibition Rates in Cancer with Continuous Infusion of Tegafur / A.Yagawa et al. / p549～549
• General Lecture 989. Not Received / /
• General Lecture 990. Bioassay of Cisplatin and Doxorubicin by HeLa Cell Clonogenic Assay / Y.Hayashi et al. / p549～549
• General Lecture 991. Determination of Unchanged Cisplatin(CDDP)in Plasma and Urine of the Patients by HPLC Using Post-column Reaction Detector / M.Kinoshita et al. / p549～549
• General Lecture 992. Phase II Study of Carboplatin in Untreated Non-small Cell Lung Cancer / S.Ryu et al. / p550～550
• General Lecture 993. Pilot Study of Combination Chemotherapy with CDDP and CBDCA for Non-small Cell Lung Cancer / M.Shibuya et al. / p550～550
• General Lecture 994. Not Received / /
• General Lecture 995. Combination Chemotherapy with Adriamycin, Carboplatin, and Etoposide for the Patients with Small Cell Lung Cancer(SCLC)--Preliminary Study / S.Negoro et al. / p550～550
• General Lecture 996. Adriamycin,Cisplatin,and Etoposide Combination Chemotherapy for Small Cell Lung Cancer / J Fujita et al. / p551～551
• General Lecture 997. Combination High-dose(HD)Etoposkle(E)/Cisplatin(D)Chemotherapy for Recurrent Small Cell Lung Cancer(SCLC) / N.Masuda et al. / p551～551
• General Lecture 998. Randomized Trial of Combination Chemotherapy with Mitomycin(M),Vindesine(V)and Cisplatin(P)in Non-small Cell Lung Cancer(NSCLC) / T.Shinkai et al. / p551～551
• General Lecture 999. Comparison of Vindesine plus Cisplatin or Mitomycin plus Cisplatin in the Treatment of Non-small Cell Lung Cancer / E.Shimizu et al. / p552～552
• General Lecture 1000. Phase II Study of Ifosfamide in Patients with Non-small Cell Lung Cancer / N.Kashima et al. / p552～552
• General Lecture 1001. Informed Consent about Anticancer Chemotherapy to the Family of Patients with Cancer / H.Tazawa et al. / p552～552
• General Lecture 1002. Phase I/II Study of 5-florouracil(5-FU)plus High-dose Leucovorin(LCV)in Advanced Non-small Cell Lung Cancer(NSCLC)and Metastatic Cancer to the Lung / Y.Ohe et al. / p553～553
• General Lecture 1003. Clinical Results of UFT plus Anticoagulants as Post-operative Adjuvant in Lung Cancer Patients / J.Ogawa et al. / p553～553
• General Lecture 1004. Phase II(P II)Trial for Previously Untreated Small Cell Lung Cancer(SCLC) / K.Matsui et al. / p553～553
• General Lecture 1005. Clinical Study of Combination Chemotherapy with Cisplatin(CDDP)and Vindisine(VDS)for Advanced Non-small Cell Lung Cancer / T.Goto et al. / p554～554
• General Lecture 1006. Phase II Study of a Three-Drug Combination of Ifosfamide, Cisplatin and Vindesine in Non-Small Cell Lung Cancer / A.Kozuka et al. / p554～554
• General Lecture 1007. Clinical Evaluation of CAV-EP Alternative Chemotherapy for Small Cell Lung Cancer / J.Mukai et a1. / p554～554
• General Lecture 1008. Evaluation of Alternating Chemotherapy for Small Cell Lung Cancer(SCLC)--Randomized Controlled Study / M.Kawahara et al. / p555～555
• General Lecture 1009. CAV-PVP Hybrid Chemotherapy for Small Cell Lung Cancer(SCLC) / T.Moritaka et al. / p555～555
• General Lecture 1010. Not Received / /
• General Lecture 1011. Clinical Trial of Carboplatin in Malignant Lymphoma / M.Nishikawa et al. / p555～555
• General Lecture 1012. The Comparative Study of Adriamycin(ADM)and 4-O-Tetrahydropyranyl Doxorubicine(THP)in the Treatment of Non-Hodgkin Lymphoma, Intermediate Grade and Immunoblastic Type(CHOP vs COP-THP) / A.Oyama et al. / p556～556
• General Lecture 1013. Clinical Evaluation of Combination Chemotherapy Including Etoposide for Refractory Acute Leukemia and Malignant Lymphoma / M.Komatsuda et al. / p556～556
• General Lecture 1014. Pharmacokinetic and Clinical Study of Intermediate Dose Ara-C Therapy(IDAra-C)in Patients with Acute Leukemia / T.Ueda et al. / p556～556
• General Lecture 1015. Phorbol Esters Potentiate Glucocorticoid-induced Cytotoxicity in CEM-C7 Human T-Leukemia Cell Line / K.Sato et al. / p557～557
• General Lecture 1016. Vincristine and Prednisolone(VP)and VMP(VP+6MP)Treatment for Patients with CML Crisis / Y.Araki et al. / p557～557
• General Lecture 1017. Treatment for stage II Non-Hodgkin's Lymphomas of the Waldeyer's Ring / T.Takenaka et al. / p557～557
• General Lecture 1018. Combined Modality for Localized Primary Head and Neck Non-Hodgkin's Lymphomas / Y.Kuraishi et al. / p558～558
• General Lecture 1019. A Result of a Salvage Chemotherapy for Non-Hodgkin's Lymphomas(NHL)
• 4 Drug Combination of Mitoxantrone,Etoposide,Cisplatin and Prednisolone(MEPP) / K.Ueno et al. / p558～558
• General Lecture 1020. Result of MCVP Chemotherapy for Recurrent or Refractory Non-Hodgikin's Lymphoma / K.Okabe et al. / p558～558
• General Lecture 1021. An Alternating Combination Chemotherapy for Diffuse Aggressive Lymphomas with CHOPB and POEMB / J.Mizuta et al. / p559～559
• General Lecture 1022. A Study on Lung Cancer after Curative Resection / Y.Uchiyama et al. / p559～559
• General Lecture 1023. Surgical Treatment of Renal Cell Carcinoma with Lung Metastases / A.Sasaki et al. / p559～559
• General Lecture 1024. Cytoreductive Surgery for Pulmonary Metastases of Gonadal Germ Cell Tumor / T.Goya et al. / p560～560
• General Lecture 1025. Surgical Treatment of Pulmonary Metastases / H.Suda et al. / p560～560
• General Lecture 1026. Surgical Treatment of Metastatic Spinal Tumors / T.Kushimoto et al. / p560～560
• General Lecture 1027. Score Assessment on Metastatic Tumor of the Spine for Operative Treatment / Y.Tokuhashi et al. / p561～561
• General Lecture 1028. Serial Changes of Serum CA 125 Levels Following Treatment for Ovarian Cancer
• Relation with Findings at Second Look Operation(SLO)and Their Clinical Courses / K.Kuzuya et al. / p561～561
• General Lecture 1029. Clinical Assessment of Patient with Second-Look Operation / M.Miyauchi et al. / p561～561
• General Lecture 1030. Second-look Laparoscopy on Patients with Ovarian Cancer / T.Shinozuka et al. / p562～562
• General Lecture 1031. Our Experience of the Second Look-operation in the Management of Ovarian Cancer / K.Tanaka / p562～562
• General Lecture 1032. Clinico-pathological Studies on stage Ia Cervical Carcinoma of Uterus by New FIGO Classification--Choice of Radical or Semiradical Hysterectomy for Ia₂ Carcinoma / K.Katoh et al. / p562～562
• General Lecture 1033. The Significance on Diagnostic Para-aortic and Pelvic Lymph Nodes Sampling in Early Ovarian Carcinoma / H.Tsunoda et al. / p563～563
• General Lecture 1034. A Few Problems in the Primary Surgery of Ovarian Cancer / S.Takeuchi et al. / p563～563
• General Lecture 1035. A Study of Pelvic Exenteration Performed for Gynecologic Advanced Malignancies / T.Ohisi et al. / p563～563
• General Lecture 1036. Cases Undergoing Total Pelvic Exenteration and Indications for This Operation / M.Tamura et al. / p564～564
• General Lecture 1037. Operative Procedure for Gastric Cancer in the Greater Curvature from the Viewpoint of Lymphatic Flow / K.Sawai et al. / p564～564
• General Lecture 1038. Analysis of Mediastinal Lymph Node Metastasis from Gastric Cancer Invading the Esophagus / M.Sasako et al. / p564～564
• General Lecture 1039. Not Received / /
• General Lecture 1040. Not Received / /
• General Lecture 1041. Study on Cases of Borrmann 4 Type Gastric Cancer Resection / H.Motohashi et al. / p565～565
• General Lecture 1042. Results of Surgical Treatment for Borrmann Type 4 Gastric Cancer / Y.Yonemura et al. / p565～565
• General Lecture 1043. Clinical Evaluation of Postoperative Condition Long after Left Upper Abdominal Evisceration plus Appleby's Method for Gastric Cancer / H.Furukawa et al. / p565～565
• General Lecture 1044. Relative Non-curative Resection of Gastric Cancer--Its Results and Problems / M.Hiratsuka et al. / p566～566
• General Lecture 1045. Prognostic Factors of Gastric Cancer with Serosal Invasion / H.Habu et al. / p566～566
• General Lecture 1046. Evaluation of Surgical Treatment for stage IV Gastric Cancer / H.Kanesada et al. / p566～566
• General Lecture 1047. Vascular Reconstruction in Hepatectomy in the Treatment of Hepatic Tumors / K.Mori et al. / p567～567
• General Lecture 1048. Five-year Survivals after Surgical Resection of Primary Hepatocellular Carcinomas / T.Shibata et al. / p567～567
• General Lecture 1049. Not Received / /
• General Lecture 1050. Block Resection of Hepatoduodenal Ligament for Carcinoma of the Bile Duct and Gallbladder--Evaluation of the Operative Procedure from a Viewpoint of Pathology / T.Mori et al. / p567～567
• General Lecture 1051. Evaluation of Resection of the Pancreas for Ampullary Carcinoma / T.Manabe et al. / p568～568
• General Lecture 1052. Prognostic Factors and It's Quantification in Advanced Ovarian Carcinoma / K.Kamioka et al. / p568～568
• General Lecture 1053. Treatment of Ovarian Cancer(stage III) / K.Yamamoto et al. / p568～568
• General Lecture 1054. The Role of Percutaneous Nephrostomy in Advanced Uterine Cervical Cancer / K.Sakumoto et al. / p569～569
• General Lecture 1055. A Plan of Management for Localized Renal Cell Carcinoma / F.Masuda et al. / p569～569
• General Lecture 1056. A Study of Testicular Tumors Treated at Our Clinic According to the Protocol of East Japan Testicular Tumor Study Group(EJTTSG) / Y.Hosaka et al. / p569～569
• General Lecture 1057. Evaluation of Treatment in Patients with Refractory Germ Cell Cancer / S.Hida et al. / p570～570
• General Lecture 1058. Pre-radiotherapy Chemotherapy for Advanced Esophageal Carcinoma / H.Sueyama et al. / p570～570
• General Lecture 1059. Multidisciplinary Treatment of Esophageal Carcinoma Based on Preoperative Staging / H.Ide et al. / p570～570
• General Lecture 1060. An Adjuvant Chemo-therapy against Esophageal Cancer after Radiation Therapy / Y.Hishikawa et al. / p571～571
• General Lecture 1061. Effects of Surgical Adjuvant Chemotherapy for Gastric Cancers with Serosal Invasion / J.Fujimoto et al. / p571～571
• General Lecture 1062. Not Received / /
• General Lecture 1063. Therapeutic Result of the Paranasal Sinus Cancer in Our Hospital / Y.Sakamoto et al. / p571～571
• General Lecture 1064. A Retrospective Study of 250 Cases of Carcinoma of the Maxillary Sinuses According to Periods and Methods of Treatment / K.Tanaka et al. / p572～572
• General Lecture 1065. Radiotherapy Combined with Concomitant Doxorubicin for Hypopharynx Carcinoma / K.Nishiyama et al. / p572～572
• General Lecture 1066. Clinico-histopathologic Studies of Oral Squamous Cell Carcinomas Treated with Neoadjuvant Therapy / T.Yamamoto et al. / p572～572
• General Lecture 1067. Not Received / /
• General Lecture 1068. Combination Therapy of OK-432 Intra-vesselally and Conventional Anti-cancer Drugs to Liver Cancer / A.Gohchi et al. / p573～573
• General Lecture 1069. An Attempt to Evaluate the Antitumor Effect of the Therapy by the Aspiration Cytology / Y.Iitsuka et al. / p573～573
• General Lecture 1070. Multimodality Treatment on Biliary Tract Cancer / M.Yonekawa et al. / p573～573
• General Lecture 1071. Clinical Study on Adjuvant Therapy to Operation of Carcinomas of the Pancreas and Biliary Tract--Tolerance to Adjuvant Chemotherapy / H.Hasegawa et al. / p574～574
• General Lecture 1072. Combination Therapy of Natural Human TNF-α + Natural Human IFN-α(OH-1)and Anticancer Agent / F.Hamada et al. / p574～574
• General Lecture 1073. Flow Cytometry Analysis of Cytokinetics of Pancreatic Adenocarcinoma Cell Line after Hyperthermia,Chemotherapy, or Radiation / B.Nakata et al. / p574～574
• General Lecture 1074. Whole Abdominal Irradiation by the Moving-strip Technique for Malignant Abdominal Tumor with Peritoneal Dissemination / S.Sugahara et al. / p575～575
• General Lecture 1075. Results of Combination Therapy with Tumor Resection, Intraperitoneal Infusion Chemotherapy(IPIC)and Whole Abdominal Irradiation for Patients with Severe Peritoneal Seedings of Gastrointestinal Malignancies / T.Todoroki et al. / p575～575
• General Lecture 1076. Extended Radical Mastectomy Using Preoperative Injection of Activated Carbon Particle(CH40) / T.Asaga et al. / p575～575
• General Lecture 1077. Multidisciplinary Treatment for Inflammatory Breast Cancer / M.Yoshida et al. / p576～576
• General Lecture 1078. Efficacy of Radiation Combined with Chemo-endocrine Therapy in Advanced/Recurrent Breast Cancer / T.Okawa et al. / p576～576
• General Lecture 1079. Not Received / /
• General Lecture 1080. Treatment of Non Hodgkin's Lymphoma in Eary stage / T. Yoshida et al. / p576～576
• General Lecture 1081. Results of Radiation Therapy for Stage I-II Non-Hodgkin's Lymphoma Localized in the Head and Neck--A Report of the Japanese Lymphoma Radiation Therapy Study Group / N.Masaki et al. / p577～577
• General Lecture 1082. A Preliminary Treatment Report of the Study Group of Japan for Advanced Neuroblastoma / S.Sawaguchi et al. / p577～577

「国立国会図書館デジタルコレクション（雑誌）」より